Index
account of the profits
Australia 2.6.7.5, 2.6.10, 2.7, 2.8
Brazil 3.7.2
calculation methods 2.7.2.2, 6.7.2
definitions 6.7.2
Germany 5.7.4
India 6.7.2
Japan 7.3.3.3.2, 7.7.2, 7.7.2.2
Korea (Republic of) 8.7.4.2
United Kingdom 9.5.3, 9.7.2, 9.9.1, 9.9.13
see also civil remedies; damages
Administrative Council
see also European Patent Office; European Patent Organization
Administrative Patent Judges (APJs), United States 10.2.1.3, 10.2.2.4, 10.2.3, 10.15
alternative dispute resolution 2.6.10, 3.6.7, 6.6.9, 7.6.8, 8.6.11, 9.6.17, 10.6.4
Anton Piller (“search”) orders
Australia 2.7.3
United Kingdom 9.6.5
appeals
Australia 2.2.1, 2.2.2.1, 2.2.2.4, 2.3.1, 2.5.1, 2.6.4.3, 2.9
Boards of Appeal of the European Patent Office (EPO) 11.3.3, 11.6
China 4.1.1.2, 4.1.3.1, 4.2.2.3, 4.2.3, 4.3.2, 4.3.4, 4.4, 4.5, 4.7, 4.8
Germany 5.2, 5.3.1, 5.4.1.2.8, 5.4.3, 5.6.1, 5.6.3.2, 5.6.3.4, 5.6.5.2, 5.6.5.4.3, 5.8, 5.9, 5.11.1.3.3
India 6.1.3, 6.1.4.1, 6.1.4.4.4, 6.2.2, 6.3.1, 6.4, 6.9
Japan 7.1.4, 7.2, 7.3, 7.4, 7.5.2.7, 7.5, 7.6, 7.6.1, 7.6.4.6, 7.8
Korea (Republic of) 8.1.1, 8.2, 8.3.1, 8.3.2, 8.4.1.2, 8.4.2.2, 8.4.2.9, 8.4.2.10, 8.6.2, 8.6.6, 8.8, 8.9.2.3, 8.9.6
United Kingdom 9.1.1.1, 9.1.1.2, 9.3.1.1, 9.3.1.2, 9.6.14, 9.6.16, 9.7.5, 9.8
United States 5.9.1.4, 10.1.1.2, 10.1.1.5, 10.2.1, 10.3.1, 10.3.2, 10.6.7.1.5, 10.6.13.6, 10.7.2.2, 10.10, 10.12.2, 10.12.3, 10.15
see also judgments; Table of Cases and Table of Laws and Regulations
arbitration
Australia 2.6.10
China 4.1.5
India 6.6.9
Korea (Republic of) 8.6.11, 8.6.11.4
see also mediators
attorneys
Brazil 3.2.2, 3.6, 3.7.2.2, 3.8
Germany 5.3, 5.4.3.3, 5.6.3.4, 5.6.8, 5.6.9, 5.6.10, 5.7.7.3, 5.9.2.4
Japan 7.3.3.3.3, 7.6.4, 7.6.5, 7.6.8, 7.7.2
Korea (Republic of) 8.3.2.3, 8.4.2.6, 8.6
United States 10.6.6, 10.6.10, 10.6.12, 10.6.13, 10.7, 10.7.3, 10.12.2, 10.12.3
see also lawyers
Australia 2.1–2.10, 3.1.6, 4.1.3.5, 6.6.8.4
additional damages 2.7
Administrative Appeals Tribunal reviews 2.2.2.5
administrative patent review proceedings 2.2
allocation of judges 2.6.1, 2.6.3, 2.7
alternative procedures 2.6.3, 2.6.5.4, 2.6.10
Anton Piller (“search”) orders 2.7.3
appeals 2.2.1, 2.2.2.1, 2.2.2.4, 2.3.1, 2.5.1, 2.6.4.3, 2.9
arbitration 2.6.10
balance-of-convenience influences in granting interlocutory injunctions 2.6.4
barristers and solicitors 2.3.1.2, 2.6.1, 2.6.3, 2.7.4
Calderbank offers 2.7.4.4
case management conference (CMC) 2.6.7
certificate of contested validity 2.7.3
civil courts and judges 2.3, 2.4, 2.5.1, 2.6, 2.7, 2.9, 2.10
civil remedies 2.4.2, 2.6.2, 2.6.4, 2.6.7.5, 2.6.10, 2.7, 2.8
claim construction 2.2.2.2, 2.2.2.3, 2.4, 2.5.1, 2.6.2, 2.6.3, 2.6.7
claim forms 2.6
Commissioner of Patents 2.2.2, 2.3
common general knowledge (CGK) 2.2.2.3, 2.4.2, 2.5.1, 2.6.7
common law 2.7.2.1
compromise offers 2.7.4.4
compulsory licenses 2.10.1
concurrent expert evidence/witnesses 2.6.7.4, 2.6.8
confidentiality issues 2.6.5.3, 2.6.9
costs/expenses 2.6.3, 2.6.7.5, 2.6.10, 2.7.4
counterclaims 2.4, 2.6, 2.7.4, 2.8.2
criminal jurisdiction 2.3.1.1
cross-examination of evidence 2.4.2, 2.6.7
damages 2.6.4, 2.6.7.5, 2.6.10, 2.7.2, 2.8
defenses 2.4, 2.6.3, 2.6.5, 2.6.6, 2.6.7
disclosures 2.5.1, 2.6.5, 2.6.9
discovery processes 2.6.5, 2.6.9, 2.6.10, 2.7.2
early case management (preparatory proceedings) 2.6.3
education/training provisions 2.3.2, 2.6.8
English law influences 2.1
evidence 2.2.2.2, 2.2.2.3, 2.3.1, 2.4.1, 2.4.2, 2.5.1, 2.6.3, 2.6.6.3, 2.6.7, 2.9, 6.6.8.4
expert conferences/joint-reports 2.6.7.3, 2.6.8
expert evidence/witnesses 2.2.2.2, 2.2.2.3, 2.3.1, 2.4.2, 2.5.1, 2.6.3, 2.6.7, 2.6.8, 2.7.4, 6.6.8.4
Federal Court of Australia 2.2, 2.3, 2.4.2, 2.6, 2.7, 2.9, 2.10
file wrapper rule 2.5.1.6
Full Court of the Federal Court 2.2.2.4, 2.3, 2.9
High Court of Australia 2.2.2.4, 2.3.1
hindsight issues 2.2.2.3
hot-tubbing procedures 2.4.1, 2.6.7.4
importation prohibitions 2.10
injunctions 2.4.2, 2.6.2, 2.6.4, 2.6.5, 2.6.10, 2.7.1, 2.8
innovation patents 2.1.1, 2.2.1, 2.2.2.7
innovative step 2.1.1
interlocutory injunctions 2.4.2, 2.6.2, 2.6.4, 2.6.5, 2.6.10, 2.7.4
inventive step 2.2.2.1, 2.2.2.3, 2.5.1, 2.6.3
jargon dictionary terms 2.5.1.4
judges 2.3, 2.4, 2.5.1, 2.6, 2.9
judgments 2.6.4, 2.6.6, 2.7, 2.8, 2.9
judicial institutions 2.2, 2.3
judicial patent proceedings 2.1.1, 2.2, 2.3, 2.6, 2.7, 2.8, 2.10
judicial reviews 2.2.2.1.3, 2.2.2.5
lost-sales damages calculation method 2.7.2.1
Mareva (“freezing/asset-protection”) injunctions 2.7.3
National Courts Framework 2.3.1
national practice areas (NPAs) 2.3.1, 2.4, 2.6.1, 2.6.3
“no reasonable prospect of success” summary adjudications 2.6.6.2, 2.6.6.3
noninfringement declaration applications 2.8.1
nonpublication/suppression orders 2.6.9
notices to produce documents 2.6.5.4
obviousness and insufficiency 2.2.2.1, 2.2.2.3, 2.5.1, 2.6.7
opposition proceedings 2.2
overview of the patent system 2.1
patent applications 2.1.2, 3.1.6
patent infringements 2.2.1, 2.2.2.2, 2.3, 2.4, 2.5, 2.6.1, 2.6.2, 2.6.3, 2.6.4, 2.6.5, 2.6.7, 2.7, 2.8
patent institutions 2.2
patent invalidity 2.2, 2.3, 2.4, 2.5.1.3, 2.6.2, 2.6.3, 2.6.6.3, 2.6.7, 2.9
patent monopolies 2.5.1
patent revocations 2.2.2.1.3, 2.2.2.4, 2.3, 2.4, 2.6.1, 2.6.2, 2.6.3, 2.6.7, 2.7.3
“person skilled in the art” determinations 2.2.2.3.4, 2.5.1.4, 2.6.7.1
Pharmaceutical Benefits Scheme 2.6.4
position statements 2.6.7.2
post-grant determination issues 2.2.2.1, 2.6.1
practice notes 2.2.1, 2.4.2, 2.5.1, 2.6, 2.7.3, 2.7.4
pre-grant determination issues 2.2.2.1
preaction/preliminary discovery 2.6.5.5
prior art 2.2.1, 2.2.2.3, 2.5.1, 2.6.3, 2.6.6.3, 2.6.7
product descriptions 2.6.7.2, 2.6.8
public interest considerations 2.10
publication/dissemination of judgments 2.6.9, 2.7.3
quia timet basis interlocutory injunctions 2.6.4.4
“reasonable license fee” damages calculation method 2.7.2.1
Regional Comprehensive Economic Partnership 4.1.3.5
responding to claims 2.4, 2.6, 2.7.4
security for costs 2.7.4.3
sources of law 2.1
statements of case 2.4.1, 2.6.2
subpoenas to produce documents 2.6.5.4
summary adjudication 2.6.6
threats actions 2.8.2
tort law 2.7.2.1
trademark institutions 2.3.1.1
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 2.10
undertakings as to damages 2.6.4.3
“user principle basis” damages calculation method 2.7.2.1
venue, jurisdiction and case assignment rules 2.3, 2.6.1
witnesses 2.2.2.2, 2.2.2.3, 2.5.1, 2.6.7, 2.6.8, 6.6.8.4
see also Table of Cases and Table of Laws and Regulations
Australian Patent Office 2.2, 2.4.2
barristers and solicitors
Australia 2.3.1.2, 2.6.1, 2.6.3, 2.7.4
United Kingdom 9.3.1.2, 9.6.13, 9.9.1
bifurcation (separate trials) ground rules
Brazil 3.3.3
Korea (Republic of) 8.3.1.3
United States 10.6.13.1, 10.6.13.5, 10.12.2.11.1
see also patent infringements; patent invalidity
Boards of Appeal of the European Patent Office (EPO) 9.1.1.3, 11.1–11.6
accelerated proceedings 11.6.5.2
Case Law of the Boards of Appeal (2022) 11.3.2.2
case management 11.6
confidentiality issues 11.6.7
convergent approach 11.6
costs 11.6.10
decisions/judgments 11.6.9
definition 11.2–11.3, 11.6.1, 11.6.2, 11.6.4
early case management (preparatory proceedings) 11.6.5
early exchanges with the parties 11.6.5.3
education/training provisions 11.3.4
Enlarged Board of Appeal 11.3.1, 11.3.2.3
evidence 11.6.3, 11.6.4, 11.6.5, 11.6.6
expert evidence/witnesses 11.6.6
first and final judicial instance 11.3.2
judicial patent proceedings 11.2–11.6
languages used 11.6.8.3
listing of cases 11.6.5.4
oral proceedings 11.6.8, 11.6.9
patent infringements 11.3.3, 11.5, 11.6.2.1, 11.6.5.2
patent invalidity 11.3.3, 11.4
professional representatives 11.6.2.3, 11.6.10
rapporteur for the preliminary study 11.6.5
responding to claims 11.6.3
statements of case 11.6.3
Technical Boards 11.2.1, 11.3.2, 11.6.2, 11.6.6
trials/hearings 11.6.8
venue, jurisdiction and case assignment rules 11.6.2
see also European Patent Office
Bolar (Roche – Bolar) exemption
Brazil 3.11.2.2
China 4.3.4.5
Germany 5.5.3.4
border measures 5.10, 7.9, 10.12
1st Judicial Administrative Region 3.3.2
absolute/relative jurisdiction contrasts 3.6.1
abstract requirements 3.1.3.2, 3.2.3
administrative patent review proceedings 3.2
alternative procedures 3.6.3, 3.6.7
appeals 3.2.4, 3.3.1, 3.8, 3.9
attorneys 3.2.2, 3.6, 3.7.2.2, 3.8
bankruptcy issues 3.6.1.2, 3.12
Bolar (Roche – Bolar) exemption 3.11.2.2
burden of proof 3.5.1.1, 3.5.2, 3.6.2.2, 3.6.3, 3.9.2
calendar for the procedural acts 3.6.3
case management 3.3, 3.6, 3.6.3, 3.9, 3.12
certificates of addition 3.1.2, 3.2.3, 3.2.4
challenges to improve case management 3.12
civil courts and judges 3.1.1, 3.3, 3.4, 3.6, 3.7, 3.8, 3.12
civil remedies 3.3, 3.4, 3.5.1.1, 3.6.3, 3.7, 3.8, 3.9, 3.12
claim classifications 3.1.3.3, 3.2, 3.5
claim construction 3.1.3, 3.1.4, 3.1.6, 3.2.2, 3.2.3
claim forms 3.2.3, 3.2.4, 3.6.2
clarification motions 3.9.3
“cognizance” civil procedure phase 3.3, 3.6.2, 3.6.3, 3.9
complaint documents 3.6.2, 3.7.1
compulsory licenses 3.2.3.3, 3.11.1.3, 3.11.2.2
confidentiality issues 3.2.3.5, 3.2.4, 3.6.6, 3.6.7
consent/license defenses 3.5.2.1
costs/expenses 3.1.6, 3.2.3, 3.2.4, 3.6.2, 3.7.1, 3.7.2, 3.9
counterclaims 3.6.2, 3.6.2.3, 3.9
criminal proceedings 3.3.3, 3.5.1.1, 3.5.1.2, 3.5.1.3, 3.6.3, 3.6.5, 3.10
cross-examination of evidence 3.6.5
damages 3.3.3, 3.4, 3.5.1.1, 3.7.1, 3.7.2, 3.8, 3.9
defenses 3.2.4, 3.4, 3.5.2, 3.6.1, 3.6.2.2
dependent/independent claim classifications 3.1.3.3, 3.5
direct patent infringements 3.5
disclosures 3.1.3.4, 3.2.3, 3.6.6, 3.11.2
dismissed applications 3.2.4, 3.9
divergent-decisions appeals 3.9, 3.9.7
doctrine of equivalents 3.5, 3.5.1.3, 3.5.1.4
education/training provisions 3.2.1, 3.3.4, 3.6.7
employment/self-employment relationships 3.1.5
enforcement of judgments 3.8
English law influences 3.1.1
evidence 3.1.3.4, 3.2.3, 3.2.4, 3.3.4, 3.6, 3.6.5, 3.7.1, 3.9
examinations 3.2.4, 3.6.1, 3.6.5, 3.11.2
experimental/research privilege 3.11.2.2
expert evidence/witnesses 3.6.3, 3.6.5
extraterritorial patent infringements 3.5.1.5
federal courts 3.3, 3.4, 3.6, 3.12
Federal Supreme Court (STF) 3.1.6, 3.3.1, 3.9, 3.9.5, 3.9.6, 3.9.7
final compliance with the decision 3.8, 3.8.2
first-sale exhaustion doctrine 3.5.2.1
first-to-file rule 3.1.4, 3.2.3
forgery 3.4
fraud 3.4
generic drugs 3.11.2
hearings 3.6.3
historical background 3.1.1
importation prohibitions 3.1.4, 3.5.1.1, 3.5.1.5
indemnity guarantees in the national defense interests 3.2.3.6
indirect patent infringements 3.5
injunctions 3.3.3, 3.7, 3.8, 3.12
Intellectual Property, Innovation, and Development Academy 3.2.1
Intellectual Property Training and Continued Education Division 3.2.1
interim injunctions 3.7.1, 3.12
interlocutory appeals 3.9.2, 3.9.4, 3.9.6
interlocutory decisions/orders 3.9
interlocutory injunctions 3.7.1
internal interlocutory appeals 3.9.4, 3.9.6
inventive step 3.1.1, 3.1.2, 3.1.3.4, 3.1.3.5, 3.2.3, 3.4, 3.11.2
inventors/authors and patent ownership 3.1.4, 3.1.5, 3.5
jargon dictionary terms 3.5.1.3
joinder of actions 3.6.1.1, 3.12
Journal of Industrial Property (RPI) 3.2.3, 3.2.4
judges 3.3, 3.4, 3.6, 3.7, 3.8, 3.12
“judgment satisfaction” civil procedure phase 3.3, 3.9
judgments 3.2.4, 3.3, 3.6.4, 3.7, 3.8, 3.9
judicial institutions 3.1.1, 3.2.4, 3.3, 3.4, 3.6, 3.9, 3.11, 3.12
judicial patent proceedings 3.1.1, 3.1.2, 3.1.4, 3.2.4, 3.3, 3.4, 3.6, 3.11, 3.12
languages used 3.2.2
licenses 3.2.3.3, 3.5.2.1, 3.11.1, 3.11.2.2
medicaments 3.3.1, 3.1.6, 3.11.2
national defense applications 3.2.3.5, 3.2.3.6
National Institute of Industrial Property (INPI) 3.1.1, 3.1.3.4, 3.1.6, 3.2, 3.3.4, 3.4, 3.6, 3.11
non-patentable inventions 3.1.3.7, 3.2.4
novelty 3.1.1, 3.1.2, 3.1.3.4, 3.1.3.5, 3.2.3.1, 3.4, 3.11.2
nullity proceedings 3.1.2, 3.2.3.8, 3.2.4, 3.3, 3.4, 3.5.2, 3.6.1, 3.6.2, 3.6.3, 3.8.2
obviousness and insufficiency 3.1.3.5
offer of license 3.11.1.2
overview of the patent system 3.1, 3.6.1
ownership issues 3.1.4, 3.1.5, 3.5
patent amendments 3.2.3.8
patent applications 3.1.1, 3.1.2, 3.1.3, 3.1.4, 3.1.7, 3.2.2, 3.2.3, 3.2.4, 3.11.2
patent definition 3.1.1, 3.1.2, 3.1.3
patent infringements 3.1.1, 3.1.4, 3.3, 3.4, 3.5, 3.6, 3.7
patent institutions 3.1.1, 3.1.3.4, 3.2, 3.4, 3.6.1, 3.11
patent invalidity 3.1.1, 3.1.2, 3.1.3, 3.2.3.8, 3.2.4, 3.3, 3.4, 3.5.2, 3.6.1, 3.6, 3.8.2
Patent Law Treaty 3 3.4
patent monopolies 3.1.1
patent revocations 3.9.1, 3.9.2, 3.11.1.3.5
patent-granting processes 3.1.3, 3.1.6, 3.2.3, 3.2.4, 3.11.2
“person skilled in the art” determinations 3.1.3.2, 3.1.3.5, 3.2.3
pharmaceutical products 3.3.1, 3.1.6, 3.11.2
post-issuance amendments/corrections 3.2.3.8
pretrial 3.6.3
prior art 3.1.3.4, 3.1.3.5, 3.2.3.1, 3.2.4
prior consent by ANVISA regarding pharmaceutical patents 3.11.2
priority 3.1.3.4, 3.2.3, 3.4, 3.5.2, 3.6.3
product descriptions 3.1.3, 3.1.6, 3.2.3, 3.11.2
prohibition actions 3.3.3
provisional compliance with the decision 3.8, 3.8.1
public interest considerations 3.2.3.5, 3.2.3.6, 3.6.6, 3.11.2
publication in the RPI 3.2.3, 3.2.4, 3.11.1
PUSH-INPI system 3.2.4
reinstatements 3.2.4
responding to claims 3.6.2.2, 3.6.2.3
search and seizure remedies 3.7.3, 3.10
shelving circumstances 3.2.3.7
specialized IP courts 3.3.2, 3.12
specification requirements 3.1.3, 3.1.6, 3.2.3, 3.11.2
statements of case 3.6.2
Superior Court of Justice (STJ) 3.3.1, 3.4, 3.6.1, 3.9, 3.9.5, 3.9.6, 3.9.7
term restoration requests 3.2.3.7
term/expiration times 3.1.6, 3.2.3.7
testimonial evidence 3.6.5.2
time limits for proceedings 3.2.4, 3.6.2, 3.6.3, 3.6.5, 3.7, 3.9, 3.11
transgenic microorganisms 3.1.3.7
trials 3.6.3
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 3.1.1, 3.2.1, 3.5.1.1, 3.11.2.1
United Kingdom 3.1.1
utility model patents 3.1.1, 3.1.2, 3.1.3, 3.1.6, 3.2.3, 3.5, 3.11.2
venue, jurisdiction and case assignment rules 3.3, 3.4, 3.6
voluntary licenses 3.11.1
witnesses 3.6.5
writs of mandamus 3.3.3
see also Table of Cases and Table of Laws and Regulations
Brazilian Health Regulatory Agency (ANVISA) 3.11.2
Brazilian Intellectual Property Association 3.11.2
Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure 3.2.3, 4.1.3.5, 6.1.4
burden of proof
Brazil 3.5.1.1, 3.5.2, 3.6.2.2, 3.6.3, 3.9.2
China 4.1.1.2, 4.3.2.4, 4.3.2.5.4, 4.3.4.3, 4.5.4.2, 4.6.1.2
Germany 5.4.2.1.3, 5.5.3, 5.6.6
India 6.1.4.4.4, 6.6.1, 6.6.7, 6.8.2
Japan 7.5.2.2, 7.5.3.1, 7.6.4.1, 7.6.4.2, 7.6.5.1, 7.7.2.1
Korea (Republic of) 8.5.2.4, 8.5.3, 8.6.1
United States 10.2.2.4.3.5, 10.6.7, 10.6.9, 10.6.13.2.3, 10.6.13.3, 10.15
Case Law of the Boards of Appeal (2022) 11.3.2.2
case management conference (CMC)
Australia 2.6.7
United Kingdom 9.6.4, 9.9.1.3, 9.9.4, 9.9.5–9.9.7
United States 10.6.6, 10.6.9.2, 10.6.13.2
see also early case management; pretrial
China 3.1.6, 4.1–4.9, 7.1.3, 7.2, 10.13.1.2
act preservation 4.1.3.3, 4.5.5.3.5, 4.6.2
administrative cases involving invention/utility-model patent grant and confirmation 4.1.3.3, 4.7
administrative regulations 4.1.3, 4.3.2.7, 4.5.5, 4.7, 4.8
advisers 4.6.3
aesthetic appeal of designs 4.8.6.3.3
aiding and abetting infringements 4.1.3.1, 4.3.3
Anti-monopoly Commission 4.5.4.2
apologies 4.4
appeals 4.1.1.2, 4.1.3.1, 4.2.2.3, 4.2.3, 4.3.2, 4.3.4, 4.4, 4.5, 4.7, 4.8
arbitration 4.1.5
Australia 4.1.3.5
bilateral international treaties 4.1.3.5
Bolar (Roche – Bolar) exemption 4.3.4.5
burden of proof 4.1.1.2, 4.3.2.4, 4.3.2.5.4, 4.3.4.3, 4.5.4.2, 4.6.1.2
business method patents 4.1.3.4
cessation of infringement 4.4, 4.6.2
civil courts and judges 4.1.3, 4.1.4, 4.1.5, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8
civil liabilities/remedies 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.2.1, 4.3.2.7, 4.3.4.3, 4.4
civil remedies 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.2.1, 4.3.2.7, 4.3.4.3, 4.4, 4.6.2.2.4, 4.9
closed composition claims 4.3.1.6
commercial success assessments of inventiveness 4.7.6.2.3
common general knowledge (CGK) 4.3.2
compensation for losses 4.1.3.3, 4.4, 4.5.5.3.6, 4.6.2.2.4
compulsory licenses 4.1.1.2
computer/IT inventions 4.1.3.4, 4.1.5
confidentiality issues 4.7.5.3
confirmation administrative processes 4.1.3.3, 4.7, 4.8
conflicting applications 4.3.4.2, 4.7.5, 4.8.2.2, 4.8.6.2
costs/expenses 4.1.1.2, 4.1.5, 4.4, 4.4.2.4, 4.9
counterclaims against vexatious litigation 4.5.5.3.6
counterfeiting acts 4.1.1.2, 4.2.1, 4.9
criminal proceedings 4.1.3.1, 4.1.5, 4.4.3.5, 4.9
damages 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.2.1, 4.3.2.7, 4.4, 4.5.1, 4.5.5.3.6, 4.6.2.2.4
dedication rule 4.3.2.6
defense of abuse of rights 4.1.3.3
defense of invalidity 4.3.1.7, 4.3.2.7, 4.3.4.1, 4.5.5.3.2, 4.8.9
defenses 4.1.3.3, 4.3.4, 4.4, 4.5, 4.7.5, 4.8.9
departmental rules 4.1.3.4, 4.3.2.7
design patent product category 4.8.4.3
design patents 4.1.1, 4.1.3.1, 4.1.3.4, 4.2.3.1, 4.2.3.2.2, 4.3.4.3, 4.6.2, 4.7.12, 4.8
determination issues 4.3.1, 4.3.2, 4.4.3, 4.7, 4.8
disclosures 4.4.2.5, 4.6.1.2, 4.7.9
discovery processes 4.4.2.5, 4.6.1.2
doctrine of equivalents 4.3.1.2, 4.3.2.2, 4.3.2.4, 4.3.4.1
doctrine of estoppel 4.3.2.4
documentary evidence 4.4.2.5, 4.6.1.2, 4.8.2
double-patenting avoidance 4.3.4.4, 4.7.4, 4.8.2.2, 4.8.6.2, 4.8.6.3
drawings 4.3.1.2, 4.3.1.3, 4.3.1.7, 4.3.2, 4.7.3, 4.7.10, 4.7.12, 4.8.2.2, 4.8.4
employees/employers 4.5.2.1
enforcement issues 4.1.1.2, 4.1.4, 4.1.5, 4.3.2.7
equity/options/dividends incentives 4.1.1.2
errors/defects in claims 4.3.1.7, 4.8.2
evidence 4.1.1.2, 4.1.3, 4.1.5, 4.3.4, 4.4, 4.6
examinations 4.1.1.2, 4.1.3, 4.3.1.3, 4.3.2.4, 4.6.2, 4.7, 4.8
exhaustion principle 4.3.4.5
experimental/research privilege 4.3.4.5
experiments 4.1.3.4, 4.3.4.5, 4.7.9.1
experts 4.6.3
first-to-file rule 4.3.4.4, 4.7.4
foreign elements in trials 4.6.4
FRAND (fair, reasonable and nondiscriminatory) 4.5.4.1
functional claims 4.3.1.4, 4.3.2.3, 4.7.3.1, 4.8.6.3.3
General Office of the Communist Party of China’s Central Committee 4.6.1.3
graphical user interfaces 4.1.3.4
Guidelines for Building a Powerful Country with Intellectual Property Rights (2021–2035) 4.1.5
Guidelines for Patent Examination 4.1.3, 4.3.1.4, 4.3.1.6, 4.7
guiding cases 4.1.4, 4.1.5, 4.3.1.4, 4.3.2.5.3, 4.6.3.1
High People’s Courts (HPCs) 4.2.2, 4.5.4.1
historical background 4.1
importation prohibitions 4.3.2.5.3, 4.3.2.8, 4.3.4.5
inspections 4.1.3
Intellectual Property Court of the Supreme People’s Court 4.1.3.3, 4.1.5, 4.2.3, 4.5.5.3
intellectual property courts 4.1.3.3, 4.1.5, 4.2.3, 4.5.5, 4.6
intentional infringement punitive damages 4.4.3.2
Intermediate People’s Courts 4.2.2, 4.5.4.2
international treaties 4.1.1.2, 4.1.2, 4.1.3.5
invention patents 4.1.1, 4.1.3.1, 4.1.3.4, 4.2.3.1, 4.2.3.2.2, 4.3.1, 4.3.2, 4.3.3, 4.3.4, 4.5.2, 4.7, 4.8
invention-creations made through cooperative/commissioned development ownership disputes 4.5.2, 4.7.4
inventive steps 4.3.1, 4.3.2.5, 4.3.4.2, 4.7.6
inventiveness definition 4.7.6, 4.7.9, 4.8.6.3
joint infringements 4.1.3.1, 4.3.3
judges 4.1.3, 4.1.4, 4.1.5, 4.2, 4.3, 4.6, 4.7, 4.8, 4.9
judgments 4.1.3, 4.1.4, 4.3.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
judicial administrative structure overview 4.2.2
judicial institutions 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
judicial interpretations 4.1.3.1, 4.1.3.3, 4.1.4, 4.1.5, 4.3.1, 4.3.2, 4.4, 4.5.4.1, 4.5.5, 4.6.1, 4.6.2, 4.7
judicial IP policies 4.1.5
judicial patent proceedings 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
Korea (Republic of) 4.1.3.5
languages used 4.3.1.7
laws’ overview 4.1.3, 4.1.5, 4.2, 4.8.5
legal basis to hear cases 4.1.3
legitimate source defense 4.3.4.3, 4.4.1
lost-profits damages calculation method 4.4.2, 4.4.3.4
lost-sales damages calculation method 4.4.2, 4.4.3.4
medicaments 4.1.1.2, 4.1.3.3, 4.2.3.2.3, 4.3.1.6, 4.3.2.5.5, 4.3.4.5, 4.5.4.1, 4.5.5, 4.7.2.2
Military Court of the People’s Liberation Army 4.1.3.3
misappropriation/unauthorized-use of others’ technical secrets 4.5.2, 4.5.2.3
morality violations 4.7.2, 4.8.2.2
multilateral international treaties 4.1.1.2, 4.1.2, 4.1.3.5
national emergency contingencies 4.1.1.2, 4.4.3.3, 4.7.5.3
National Intellectual Property Strategy 2008 4.1.1.2
National People’s Congress (NPC) 4.1.1, 4.1.3, 4.2.3, 4.5.5.3
non-infringement declaration disputes 4.5.1
non-patentable inventions 4.7.2, 4.8.2.2
notices to produce documents 4.4.2.5, 4.6.1.2
novelty 4.1.1.2, 4.1.3.4, 4.3.1, 4.3.2.5.4, 4.3.4.2, 4.7.5
obviousness and insufficiency 4.3.4.1, 4.7.6, 4.7.10
Opinions on several IP issues 4.1.5, 4.5.5, 4.6.1.3, 4.6.3
ordinary consumers’ understanding of design products 4.8.3
overview of the patent system 4.1, 4.2
ownership issues 4.2.1, 4.2.3.2, 4.5.2, 4.7.4
patent amendments 4.3.2.4, 4.7.12
patent applications 3.1.6, 4.1, 4.3.1, 4.3.2.4, 4.3.2.7, 4.5.2, 4.7, 4.8, 7.1.3, 7.2
patent contract disputes 4.5.3, 4.5.4
Patent Cooperation Treaty (PCT) 4.1.1.2, 4.1.2, 4.1.3.5
patent evaluation reports 4.1.1.2
patent infringements 4.1.1.2, 4.1.3, 4.1.5, 4.2.1, 4.2.3.2, 4.3, 4.4, 4.5, 4.6, 4.8, 4.9
patent institutions 4.1, 4.2, 4.3.2.4, 4.3.2.7, 4.5.5, 4.7, 4.8, 7.2
patent invalidity 4.1.1, 4.1.3.4, 4.1.5, 4.2.1, 4.3.1.7, 4.3.2.7, 4.3.4, 4.4.2.3, 4.5.5.3.2, 4.7, 4.8
patent monopolies 4.1.5, 4.5.4, 4.5.4.2
Patent Reexamination Board 4.1.1.2, 4.3.1.7, 4.7
patent revocations 4.1.1.2, 4.4.2.3
patent-granting/confirmation administrative processes 4.1.3.3, 4.7, 4.8
people’s courts 4.1.5, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8
“person skilled in the art” determinations 4.3.1.2, 4.3.1.4, 4.3.2.2, 4.7.6, 4.7.8, 4.7.9, 4.7.10, 4.7.12
Peru 4.1.3.5
pharmaceutical products 4.1.1.2, 4.1.3.3, 4.2.3.2.3, 4.3.2.5.5, 4.3.4.5, 4.5.4.1, 4.5.5, 4.7.2.2.3, 4.7.9.1
practical use of inventions/utility-models 4.7.7
pre-litigation 4.6.2
preliminary examinations of design patent applications 4.8
Primary People’s Courts 4.2.2
prior art 4.1.1.2, 4.3.2, 4.3.4.1, 4.5.5.3.2, 4.7.5, 4.7.6, 4.7.9, 4.8.2.2, 4.8.3, 4.8.5, 4.8.6, 4.8.9
prior designs 4.8.5, 4.8.6, 4.8.7, 4.8.8, 4.8.9
prior-art opposite teachings 4.7.6.2.4
prior-art technical motivation 4.7.6.1.3, 4.7.6.2.3, 4.7.6.2.4, 4.8.6.3.2
prior-use rights (first-to-file compensation) defense 4.3.4.4, 4.5.5.3.2
process infringements 4.3.2.5
product descriptions 4.3, 4.7, 4.8
product-by-process claims 4.3.2.5.2
proportional compensation 4.4.2, 4.4.3
public interest considerations 4.1.1.2, 4.1.4, 4.3.1.2, 4.4.3.3, 4.5.5, 4.7.2, 4.7.5.3, 4.7.12.1.2, 4.8.2.2
publication/dissemination of judgments 4.3.2.8
punitive damages 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.4, 4.4.3
reasonable expenses 4.4.2.4
reasonable royalties 4.4.2, 4.4.3.4
reexaminations 4.1.1.2, 4.3.1.7, 4.7, 4.8
reform/development of IP case trials 4.1.5, 4.6.1.3
Regional Comprehensive Economic Partnership 4.1.3.5
Regulations on Patent Commissioning 4.1.3.2
remuneration/rewards for inventors/designers 4.5.2.1.4
reputation/credibility civil remedies 4.4
reverse act preservation e-commerce platforms 4.6.2.2.5
royalties 4.2.1, 4.3.2.8, 4.4.2, 4.4.3.4, 4.5.4
scope of protection 4.1.1.2, 4.1.3, 4.2.3.2, 4.3, 4.7, 4.8
serious/severe circumstances of infringements 4.4.3.3, 4.4.3.5
service invention-creations ownership disputes 4.5.2
settlements 4.1.1.2, 4.1.5, 4.4.2.3
specialized intellectual property courts 4.1.3.3, 4.1.5, 4.2.3, 4.5.5, 4.6
standard-essential patents (SEPs) 4.5.4
Standing Committee of the National People’s Congress (NPC) 4.1.1, 4.1.3.1, 4.1.3.2, 4.2.3, 4.5.5.3
State Council 4.1.1.2, 4.1.3.2, 4.3.1.7, 4.3.2.7, 4.5.3, 4.5.4.2, 4.5.5, 4.6.1.3, 4.6.2.2, 4.7, 4.8.2, 4.8.4.3, 4.8.6.2
subject matter examinations 4.7.2
Superior People’s Courts 4.2.2
Supreme People’s Court (SPC) 4.1.3.1, 4.1.3.3, 4.1.4, 4.1.5, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8
technical appraisal conclusions 4.6.3
technical fact-finding mechanisms 4.6.3
technology/IT-based courts 4.1.5
temporary protection of invention patents 4.3.2.8
term/expiration times 3.1.6, 4.1.1.2
threats actions 4.5.5.3.6
time limits for proceedings 4.1.5, 4.4.3.1, 4.5, 4.7.5
tort law 4.3.3
transfers of jurisdiction 4.2.2, 4.6.4
trials 4.1.3, 4.1.5, 4.4, 4.6, 4.7, 4.9
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 4.1.1.2, 4.1.3.5, 4.3.2.5.4, 4.8.6
United States 4.1.3.5
use-environment features 4.3.1.5
utility model patents 4.1.1, 4.1.3.1, 4.1.3.4, 4.3.1, 4.3.2, 4.3.4, 4.6.2, 4.7, 4.8.6.1
venue, jurisdiction and case assignment rules 4.2, 4.6
World Intellectual Property Organization (WIPO) 4.1.1.1, 4.1.3.5, 4.1.5
World Trade Organization (WTO) 4.1.3.5
wrongful applications for act preservation 4.6.2.2
see also Table of Cases and Table of Laws and Regulations
China National Intellectual Property Administration (CNIPA) 4.1.3, 4.1.5, 4.3.2.4, 4.3.2.7, 7.2, 4.5.4.1, 4.5.5, 4.7, 4.8.2, 4.8
civil courts and judges
Australia 2.3, 2.4, 2.5.1, 2.6, 2.7, 2.9, 2.10
Brazil 3.1.1, 3.3, 3.4, 3.6, 3.7, 3.8, 3.12
China 4.1.3, 4.1.4, 4.1.5, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8
Germany 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.11
India 6.1, 6.2.2, 6.3, 6.5, 6.6, 6.7, 6.8, 6.9, 6.11
Japan 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
Korea (Republic of) 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8, 8.9
United Kingdom 9.1.1, 9.2, 9.3, 9.6, 9.7, 9.8
United States 5.6.2.1, 10.1, 10.2.1, 10.2.2.4, 10.2.3, 10.3, 10.4, 10.5, 10.6, 10.10, 10.14, 10.15
civil remedies
Australia 2.4.2, 2.6.2, 2.6.4, 2.6.7.5, 2.6.10, 2.7, 2.8
Brazil 3.3, 3.4, 3.5.1.1, 3.6.3, 3.7, 3.8, 3.9, 3.12
China 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.2.1, 4.3.2.7, 4.3.4.3, 4.4, 4.6.2.2.4, 4.9
Germany 5.1.1, 5.3.1, 5.4.1.2, 5.4.3.4, 5.6.2.1, 5.6.3.3, 5.6.4, 5.6.5, 5.6.6, 5.7, 5.8, 5.11
India 6.1, 6.5, 6.6.4, 6.7, 6.8.1.2, 6.11.3
Japan 7.3.2, 7.3.3.3.2, 7.5.3.3, 7.6, 7.6.4, 7.7
Korea (Republic of) 8.3.1.2, 8.3.2, 8.5, 8.6, 8.7
United Kingdom 9.1.1.1, 9.1.1.3, 9.5.3, 9.5.4, 9.5.5, 9.6.4.2, 9.6.5, 9.6.17, 9.7, 9.9.1, 9.9.5, 9.9.13
United States 6.7.2, 10.1.1.2, 10.1.1.7, 10.6.6, 10.6.7, 10.6.8.1, 10.6.10, 10.6.13.6, 10.7, 10.9, 10.10, 10.12.1.4, 10.12.3, 10.12.4, 10.13.2.1.4, 10.13.2.2, 10.15
see also costs/expenses; damages; injunctions
claim construction
Australia 2.2.2.2, 2.2.2.3, 2.4, 2.5.1, 2.6.2, 2.6.3, 2.6.7
Brazil 3.1.3, 3.1.4, 3.1.6, 3.2.2, 3.2.3
China 4.3.1
Germany 5.5.1, 5.6.1, 5.6.4, 5.6.5, 5.6.7.1, 5.6.10, 5.9.1
Japan 7.2.4.1.5, 7.3.2, 7.4.5.2.2, 7.5.1, 7.6.7
Korea (Republic of) 8.3.2, 8.4.2, 8.5.1, 8.7.3.2
United Kingdom 6.5.1, 9.5.2, 9.6.3, 9.9.2–9.9.4
United States 10.1.1.2, 10.2.2, 10.3.3, 10.5.1, 10.6.2, 10.6.6, 10.6.9.2, 10.6.13, 10.9, 10.12.2.8, 10.12.2.9, 10.15
see also early case management; pretrial
common law
Australia 2.7.2.1
India 6.6.4
United Kingdom 9.1.1.1
Community Patent Convention 9.1.1.3, 9.5.1
compulsory licenses
Australia 2.10
India 6.1.1, 6.1.3, 6.1.4.2, 6.1.4.4, 6.4, 6.10.1
Korea (Republic of) 8.5.3.5
see also pharmaceutical products
confidentiality issues
Boards of Appeal of the European Patent Office (EPO) 11.6.7
Brazil 3.2.3.5, 3.2.4, 3.6.6, 3.6.7
China 4.7.5.3
Germany 5.4.1.4, 5.6.1, 5.6.4.6, 5.6.6.3, 5.6.8, 5.6.9
Japan 7.6.5.1
Korea (Republic of) 8.6.7.6.2.2, 8.6.9, 8.9
United Kingdom 9.6.10, 9.6.15, 9.9.10
United States 10.2.2.4, 10.6.4, 10.6.7.1, 10.6.8.2, 10.6.12, 10.12.2.5, 10.12.2.7, 10.13.2.2
Constitutions
Brazil 3.1.1, 3.1.6, 3.3.3, 3.3.4, 3.6.1, 3.6.3, 3.9.5
Germany 5.1, 5.3.1, 5.5.3.4, 11.2.1
Korea (Republic of) 8.1
United States 6.1.1, 10.1, 10.2.3, 10.6.13
Contracting States of the European Patent Convention (EPC) 5.1.2, 11.1–11.2, 11.3.3, 11.6.10
convergent approach, Boards of Appeal of the European Patent Office (EPO) 11.6
costs/expenses
Australia 2.6.3, 2.6.7.5, 2.6.10, 2.7.4
Boards of Appeal of the European Patent Office (EPO) 11.6.10
Brazil 3.1.6, 3.2.3, 3.2.4, 3.6.2, 3.7.1, 3.7.2, 3.9
China 4.1.1.2, 4.1.5, 4.4, 4.4.2.4, 4.9
compromise offers 2.7.4.4, 9.7.4
Germany 5.3.1, 5.4.1.2, 5.4.1.3, 5.4.3.4.4, 5.6.2.1, 5.7.7, 5.9.1
indemnity basis 2.7.4, 3.2.3.6, 9.4, 10.6.6
Japan 7.7
security for costs 2.7.4.3, 5.3.1, 5.4.1.2.2.4, 5.6.5.3, 5.8.4, 5.11.1.2, 7.6.4.4, 10.6.7.1
United Kingdom 9.1.1.1, 9.4, 9.6.1, 9.6.2.2, 9.6.5, 9.6.7, 9.6.17, 9.7.3–9.7.5, 9.9.12
United States 10.6, 10.7, 10.7.3, 10.14, 10.15
see also civil remedies; damages
Court of Justice of the European Union 5.1.2
COVID-19 pandemic 2.6.10, 4.1.5, 5.6.9, 6.6.4, 6.6.7, 6.10.1, 9.6.13, 9.9.1.3, 9.9.5.1, 9.9.9
criminal proceedings
Australia 2.3.1.1
Brazil 3.3.3, 3.5.1.1, 3.5.1.2, 3.5.1.3, 3.6.3, 3.6.5, 3.10
China 4.1.3.1, 4.1.5, 4.4.3.5, 4.9
Germany 5.6.8
India 6.3.1
Korea (Republic of) 8.3.1, 8.3.2.1, 8.5, 8.6.9.2, 8.6.11, 8.9
types of crimes 8.9
United States 10.11
damages
Australia 2.6.4, 2.6.7.5, 2.6.10, 2.7.2, 2.8
Brazil 3.3.3, 3.4, 3.5.1.1, 3.7.1, 3.7.2, 3.8, 3.9
calculation methods 2.7.2.1, 4.4.2, 4.4.3, 5.7.4, 5.7.7, 6.7.2, 7.6.7, 7.7.2, 8.6.3, 8.7.4.2
China 4.1.1.2, 4.1.3.1, 4.1.3.3, 4.1.5, 4.2.1, 4.3.2.7, 4.4.2, 4.4.3, 4.5.1, 4.5.5.3.6, 4.6.2.2.4
Germany 5.4.1.2, 5.6.3.3, 5.7.4, 5.7.7
India 6.1, 6.7.2, 6.8.1.2, 6.11.3
Japan 7.3.2, 7.3.3.3.2, 7.5.3.3, 7.6, 7.6.4, 7.6.4.7, 7.6.7, 7.7, 7.7.2
Korea (Republic of) 8.5, 8.6.1, 8.6.2.2.2, 8.6.3, 8.7, 8.7.4
United Kingdom 9.1.1.3, 9.5.3, 9.5.5, 9.6.5, 9.7.2, 9.9.1, 9.9.13
United States 6.7.2, 10.6.6, 10.6.8.1, 10.6.10, 10.6.13, 10.7, 10.7.2
see also account of the profits; civil remedies; costs/expenses; lost-sales; “reasonable license fee”; reasonable royalties
defenses
Australia 2.4, 2.6.3, 2.6.5, 2.6.6, 2.6.7
Brazil 3.2.4, 3.4, 3.5.2, 3.6.1, 3.6.2.2
China 4.1.3.3, 4.3.4, 4.4, 4.5, 4.7.5, 4.8.9
Germany 5.3.1, 5.4.1.2.3, 5.4.1.2.5, 5.4.1.2.6, 5.4.3.2, 5.4.3.4, 5.5.2.3, 5.5.3, 5.6.3.3, 5.6.5, 5.7.6, 5.9.1.2
India 6.1.4.4.4, 6.5, 6.5.3, 6.5.4, 6.6.2, 6.6.4, 6.6.7, 6.7.2.2, 6.8.2
Japan 7.2.4.5, 7.4.3, 7.5, 7.5.3, 7.5.4, 7.6.2, 7.6.3, 7.6.4, 7.7.2, 7.9
Korea (Republic of) 8.5.2, 8.5.3, 8.6, 8.7.3
United Kingdom 9.6.5, 9.6.3, 9.6.13, 9.7, 9.9.2, 9.9.4
United States 10.1.1.4, 10.2.2, 10.3.3, 10.5.3, 10.6.5, 10.6.6, 10.6.8, 10.6.10.4, 10.12.1.2, 10.12.1.3, 10.12.2.5, 10.15
disclosures
Brazil 3.1.3.4, 3.2.3, 3.6.6, 3.11.2
Germany 5.4.1.3, 5.4.2.1.2, 5.4.2.2, 5.4.2.4, 5.5.3, 5.6.1, 5.6.6, 5.6.8, 5.7.3
Japan 7.4.5.2.3, 7.5.1, 7.5.2.3, 7.6.5
Korea (Republic of) 8.6.7, 8.6.9, 8.6.11, 8.7.3
United Kingdom 9.3.1.2, 9.6.7, 9.9.5.3, 9.9.6
United States 10.6.2, 10.6.8, 10.6.10.4, 10.6.12, 10.15
doctrine of equivalents
China 4.3.1.2, 4.3.2.2, 4.3.2.4, 4.3.4.1
Germany 5.5.2.3
Korea (Republic of) 8.5.2.3, 8.9.4.1
United Kingdom 6.5.1, 9.5.2, 9.6.3.3
see also patent infringements
Doha Declaration 2001 6.1.4.2, 6.1.4.4.5, 6.10.1
drawings
China 4.3.1.2, 4.3.1.3, 4.3.1.7, 4.3.2, 4.7.3, 4.7.10, 4.7.12, 4.8.2.2, 4.8.4
Germany 5.5.1
Japan 7.2.4.1.5, 7.2.4.4, 7.2.4.5.1, 7.4.5.2.7, 7.5.1.3, 7.5.3.1, 7.6.6.1
Korea (Republic of) 8.5.1.2, 8.6.3, 8.6.8
United Kingdom 9.5.2
United States 10.1.1.2, 10.2.2, 10.6.10.3
early case management (preparatory proceedings)
Australia 2.6.3
Boards of Appeal of the European Patent Office (EPO) 11.6.5
India 6.6.3
Japan 7.6.3
Korea (Republic of) 8.6.4
United States 10.6.6, 10.6.9.2, 10.12.2.9, 10.12.2.10
education/training provisions
Boards of Appeal of the European Patent Office (EPO) 11.3.4
Germany 5.3.1
Korea (Republic of) 8.3.2.3, 8.3.3, 8.4.2.6, 8.6.8
United States 10.2.1, 10.3.4, 10.6.6.2, 10.6.11, 10.12.2.10.5, 10.14
electronically stored information (ESI), United States 10.6.8
England-and-Wales/Scotland/Northern-Ireland jurisdictions
United Kingdom 9.1.1.2, 9.3.1.4, 9.3.1.5, 9.5.1, 9.6
see also United Kingdom
Enlarged Board of Appeal 11.3.1, 11.3.2.3
ePCT filing, World Intellectual Property Organization (WIPO) 3.2.3
European Commission of Human Rights 11.2.1
European Community
India 6.1.4.1
see also Table of Cases and Table of Laws and Regulations
European Convention on Human Rights 11.2.1
European Economic Area (EEA) 5.4.1.2.2.4, 5.5.3.3
European Parliament and Council
Intellectual Property Enforcement Directive 2004/48/EC 5.1.2, 5.6.5.4.2, 5.6.6.3, 5.7.5, 9.7.2
Medicinal Products for Human Use Directive 2001/83/EC 5.5.3.4
Veterinary Medicinal Products Directive 2001/82/EC 5.5.3.4
European Patent Convention (EPC) 2.1.1, 5.1.2, 7.5.1, 9.1.1.3, 9.4, 9.5.2, 11.1, 11.3.2, 11.3.3, 11.6
Contracting States 5.1.2, 11.1–11.2, 11.3.3, 11.6.10
Germany 5.1.2, 5.4.2.1, 5.4.2.4, 5.5.1, 5.6.3.3.2, 5.6.4.2, 5.6.4.4
historical background 5.1.2, 11.1
Japan 7.5.1
overview of the patent system 5.1.2, 11.1, 11.3.2, 11.3.3
United Kingdom 2.1.1, 5.1.2, 9.1.1.3, 9.4, 9.5.1, 9.5.2
see also European Patent Office; Paris Convention; Patent Cooperation Treaty
European Patent Office (EPO) 5.1.2, 5.3.1, 5.4.1.2.6, 5.4.1.2.8, 5.4.2, 5.6.1, 5.6.4.2, 6.2.1.6, 7.5.1.1, 9.1.1.2, 9.1.1.3, 9.4, 10.2.1, 11.1–11.6
“Comvik” approach 5.4.2.1
definition 5.1.2, 11.1–11.2, 11.6.1, 11.6.4
Divisions 11.2, 11.6.2, 11.6.4, 11.6.10
European Qualifying Examination 11.6.2.3
Germany 5.1.2, 5.3.1, 5.4.1.2.6, 5.4.1.2.8, 5.4.2, 5.6.1, 5.6.4.2
historical background 5.1.2, 11.1
judicial institutions 11.2–11.6
official languages (English, German, French) 11.6.8.3
opposition proceedings 10.2.1, 11.2, 11.4, 11.6.4, 11.6.10
overview of the patent system 5.1.2, 11.1–11.2
patent applications 5.1.2, 5.4.2, 7.5.1.1, 11.1.2
patent revocations 5.4.1.2.6, 5.4.2, 10.2.1, 11.2, 11.3.3, 11.6.4, 11.6.9
“person skilled in the art” determinations 11.4
Statistics and Trends Centre 11.1.2
United Kingdom 5.1.2, 9.1.1.2, 9.1.1.3, 9.4
United States 10.2.1
see also Administrative Council; Boards of Appeal; European Patent Convention
European Patent Organization
definition 11.2
see also Administrative Council; European Patent Office
European Patent Register 11.6.7
European patents
definition 7.5.1.1, 11.1, 11.3.3
see also European Patent Office
European Qualifying Examination, European Patent Office (EPO) 11.6.2.3
European Union (EU) 5.1.2, 9.1.1.2
Germany 5.1.2
UK withdrawal 9.1.1.2
see also Table of Cases and Table of Laws and Regulations
evidence
Australia 2.2.2.2, 2.2.2.3, 2.3.1, 2.4.1, 2.4.2, 2.5.1, 2.6.3, 2.6.6.3, 2.6.7, 2.9, 6.6.8.4
Boards of Appeal of the European Patent Office (EPO) 11.6.3, 11.6.4, 11.6.5, 11.6.6
Brazil 3.1.3.4, 3.2.3, 3.2.4, 3.3.4, 3.6, 3.6.5, 3.7.1, 3.9
China 4.1.1.2, 4.1.3, 4.1.5, 4.3.4, 4.4, 4.6.1
Germany 5.4.1.2, 5.4.1.3, 5.4.1.4, 5.4.3.2, 5.6.1, 5.6.4, 5.6.5.3, 5.6.5.4, 5.6.6, 5.6.10, 5.6.7, 5.9
hearsay evidence 10.6.6.2, 10.12.2.11, 10.15
India 6.2.2.2, 6.6, 6.6.7, 6.11.3
Japan 7.2.4.1.4, 7.2.4.3, 7.2.4.6, 7.4.3, 7.4.4, 7.6.2, 7.6.3, 7.6.4, 7.6.5, 7.6.6, 7.6.7
Korea (Republic of) 8.2.2.2, 8.4.2, 8.5.1, 8.6.7, 8.8
United Kingdom 5.6.1, 9.6.4, 9.6.8, 9.6.13, 9.6.14, 9.9.5.3, 9.9.7, 9.9.9
United States 5.6.1, 10.2.2, 10.5.1, 10.5.3, 10.6.3, 10.6.6, 10.6.10, 10.6.11, 10.6.13.3, 10.12, 10.15
ex parte proceedings
Germany 5.6.5
Japan 7.2.4.2, 7.2.4.4, 7.2.4.7, 7.3.3.1, 7.4.1, 7.4.2
Korea (Republic of) 8.2.2, 8.4.2.3, 8.4.2.5
exclusive marketing rights (EMRs), TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 6.1.4.1, 6.1.4.4
exhaustion principle
Brazil 3.5.2.1
China 4.3.4.5
definition 6.1.4.2
Germany 5.5.3.3
Korea (Republic of) 8.5.3.4
United States 10.1.1.3, 10.1.1.4, 10.5.3
experiments
Brazil 3.11.2.2
China 4.1.3.4, 4.3.4.5, 4.7.9.1
definitions 5.5.3.4
Germany 5.5.3.4
Korea (Republic of) 8.7.2
United States 10.1.1.4, 10.5.3
expert evidence/witnesses
Australia 2.2.2.2, 2.2.2.3, 2.3.1, 2.4.2, 2.5.1, 2.6.3, 2.6.7, 2.6.8, 2.7.4, 6.6.8.4
Boards of Appeal of the European Patent Office (EPO) 11.6.6
China 4.6.3
definitions 6.6.8
Germany 5.4.1.3, 5.6.1, 5.6.5.3, 5.6.5.4, 5.6.6.3, 5.6.7
India 6.6.5, 6.6.7, 6.6.8, 6.11.3
Japan 7.2.4.1.4, 7.6.6.1, 7.6.7
Korea (Republic of) 8.4.2.6, 8.6.5, 8.6.7, 8.9
United Kingdom 9.6.4, 9.6.8.2, 9.6.13, 9.6.14, 9.9.5.3, 9.9.7, 9.9.9
United States 10.2.2.4, 10.6.2, 10.6.6, 10.6.11, 10.6.13, 10.7.2, 10.12.2.10, 10.12.2.11.3, 10.15
file wrapper rule
Australia 2.5.1.6
first-to-file rule
Japan 7.1.1
Korea (Republic of) 8.5.3.1
United States 10.1.1.7, 10.3.3
Food and Drug Administration (FDA), United States 10.1.1.6, 10.13.2
forum shopping
Germany 5.6.3.1
United States 10.1.1.5, 10.3.2, 10.13.1.2, 10.14
FRAND (fair, reasonable and nondiscriminatory)
China 4.5.4.1
United Kingdom 9.5.4, 9.6.5.2, 9.7.1
General Agreement on Tariffs and Trade (GATT 1947) 6.1.1, 6.1.4
see also World Trade Organization
“general form” injunctions, United Kingdom 9.7
German Constitutional Court 5.3, 5.6.9, 5.9.2.1, 11.2.1
German Patent and Trademark Office (PTO) 5.1, 5.3.1, 5.4.1.2
Germany 5.1–5.11, 6.2.1.6, 10.13.1.2, 11.3.2.2, 11.3.3, 11.6.2
28 USC 1782 discovery 5.6.6.4
added matter factors 5.4.2.4
additional damages 5.7.4
administrative patent review proceedings 5.2
admissibility thresholds 5.4.1.2, 5.4.3.4, 5.5.1, 5.6.2.1, 5.6.4.3, 5.6.4.4, 5.6.5.3, 5.9.2.1
advisers 5.4.3.3, 5.6.1, 5.6.7
affidavits of witnesses 5.6.5.3, 5.6.7.2
Anglo-American trial contrasts 5.6.1, 5.6.3, 5.9.1.4
appeals 5.3.1, 5.4.1.2.8, 5.4.3, 5.6.1, 5.6.3.2, 5.6.3.4, 5.6.5.2, 5.6.5.4.3, 5.8, 5.9, 5.11.1.3.3
appeals’ complaints 5.9.2.2
appeals on points of law (cassation) 5.9.2
attorneys 5.3, 5.4.3.3, 5.6.3.4, 5.6.8, 5.6.9, 5.6.10, 5.7.7.3, 5.9.2.4
bifurcation (separate trials) ground rules 5.2, 5.3, 5.6.5.4.2
biosimilar products 5.5.3.4
Bolar (Roche – Bolar) exemption 5.5.3.4
border measures 5.6.3.1, 5.6.3.3.2, 5.10
Brussels Ia Regulation 5.6.3.1, 5.6.4.2
burden of proof 5.4.2.1.3, 5.5.3, 5.6.6
business-method-related patents 5.4.2
case management 5.6
cease-and-desist letters 5.6.2.1, 5.8.2
civil courts and judges 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.11
civil remedies 5.1.1, 5.3.1, 5.4.1.2, 5.4.3.4, 5.6.2.1, 5.6.3.3, 5.6.4, 5.6.5, 5.6.6, 5.7, 5.8, 5.11
claim construction 5.5.1, 5.6.1, 5.6.4, 5.6.5, 5.6.7.1, 5.6.10, 5.9.1
claim withdrawals 5.4.3.4.3, 5.6.10
communications with the infringer 5.6.2.1
compulsory licenses 5.5.3.3, 5.11.1
computer-implemented inventions 5.4.2, 5.11.1
confidentiality issues 5.4.1.4, 5.6.1, 5.6.4.6, 5.6.6.3, 5.6.8, 5.6.9
costs 5.3.1, 5.4.1.2, 5.4.1.3, 5.4.3.4.4, 5.6.2.1, 5.7.7, 5.9.1
counterclaims 5.6.2.1.2, 5.6.3.3, 5.9.1.2
criminal proceedings 5.6.8
cross-appeals 5.4.3.4.3, 5.9.1.2
Customs 5.10
damages 5.4.1.2, 5.6.3.3, 5.7.4, 5.7.7
de novo appeals 5.4.3.2, 5.9.1
declaratory judgment action 5.6.2.1, 5.6.3.3, 5.7.6
declaratory relief claims 5.6.2.1, 5.6.3.3, 5.7.6
defendant party overview 5.6.3.3
defenses 5.3.1, 5.4.1.2.3, 5.4.1.2.5, 5.4.1.2.6, 5.4.3.2, 5.4.3.4, 5.5.2.3, 5.5.3, 5.6.3.3, 5.6.5, 5.7.6, 5.9.1.2
destruction/recall/removal orders 5.7.2, 5.7.7, 5.8.3
direct patent infringements 5.5.2.1, 5.5.2, 5.7
disclosures 5.4.1.3, 5.4.2.1.2, 5.4.2.2, 5.4.2.4, 5.5.3, 5.6.1, 5.6.6, 5.6.8, 5.7.3
discovery processes 5.6.1, 5.6.6.3, 5.6.6.4, 5.6.8, 5.7.3
dismissals 5.6.5.4, 5.6.6.3, 5.6.9, 5.6.10, 5.9
disproportionality objections 5.1.1, 5.6.4.6, 5.7.5
doctrine of equivalents 5.5.2.3
documentary evidence 5.4.1.2, 5.4.1.3, 5.4.1.4, 5.6.7.3
drawings 5.5.1
education/training provisions 5.3.1
enforcement issues 5.1.2, 5.6.5.3, 5.6.5.4, 5.6.10, 5.8
European Patent Convention (EPC) 5.1.2, 5.4.2.1, 5.4.2.4, 5.5.1, 5.6.3.3.2, 5.6.4.2, 5.6.4.4
European Patent Office (EPO) 5.1.2, 5.3.1, 5.4.1.2.6, 5.4.1.2.8, 5.4.2, 5.6.1, 5.6.4.2
European Union (EU) 5.1.2
evidence 5.4.1.2, 5.4.1.3, 5.4.1.4, 5.4.3.2, 5.6.1, 5.6.4, 5.6.5.3, 5.6.5.4, 5.6.6, 5.6.10, 5.9
ex parte proceedings 5.6.5
examinations 5.4.1.3, 5.4.2.1, 5.4.3.4, 5.6.7
exhaustion principle 5.5.3.3
experimental/research privilege 5.5.3.4
expert evidence/witnesses 5.4.1.3, 5.6.1, 5.6.5.3, 5.6.5.4, 5.6.6.3, 5.6.7
Federal Administrative Court 5.1
Federal Court of Justice (FCJ) 5.2, 5.3, 5.4.1.3, 5.4.2, 5.4.3, 5.5.1, 5.5.2, 5.5.3, 5.6.3, 5.6.6.3, 5.6.7, 5.9.2, 5.11, 11.3.2.2
Federal Patent Court (FPC) 5.1, 5.3.1, 5.4, 5.6.3, 5.7.6, 5.9.2.2, 5.11.1
Federal Supreme Court 5.4.2
first-instance proceedings 5.3.1, 5.4
forum shopping 5.6.3.1
FRAND (fair, reasonable and nondiscriminatory) 5.6.6.4, 5.6.8
front-loading proceedings 5.4.1.2, 5.6.1, 5.6.4
functional claims 5.5.1, 5.5.2
generic drugs 5.5.3.4
Hague Convention 5.6.4, 5.6.6.4
higher regional courts 5.3, 5.6.6.3, 5.8, 5.9
historical background 5.1
importation prohibitions 5.5.2.1, 5.6.3.3.2, 5.10
indirect patent infringements 5.5.2, 5.7
information-gathering mechanics 5.6.6, 5.6.8, 5.7.3, 5.9.2
injunctions 5.1.1, 5.3.1, 5.6.2.1, 5.6.3.3, 5.6.5, 5.6.6.3, 5.7, 5.8, 5.9.1.4, 5.11.1.3.2
inspections 5.4.1.3, 5.4.2.1, 5.6.1, 5.6.6, 5.6.7
inspections/on-site-examinations of alleged infringer’s facility 5.6.6, 5.6.7
inter partes reviews (IPRs) 5.6.5.3, 5.6.5.4.2
interim injunctions 5.6.5, 5.6.6.3, 5.11.1.3.2
interpretation of claims 5.5.1, 5.9
interrogations 5.4.1.3
inventive step 5.4.1.2.2, 5.4.1.2.8, 5.4.1.3, 5.4.2.1.3
“Italian torpedo” practices 5.6.2.1.3
joinder of actions 5.4.1.2.2
judges 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9
judgments/decisions 5.3.1, 5.4.1, 5.4.2.1.2, 5.4.3.1, 5.4.3.2, 5.4.3.4, 5.6.2, 5.6.9, 5.6.10, 5.7, 5.8, 5.9
judicial institutions 5.1, 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.10, 5.11
judicial patent proceedings 5.1, 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.10, 5.11
languages used 5.4.1.2, 5.6.4.3, 5.6.9
licenses 5.5.3.3, 5.6.3.3, 5.7.4, 5.7.7, 5.11.1
lost-profits damages calculation method 5.7.4
Markman hearings 5.6.1
medicaments 5.5.3.3, 5.5.3.4, 5.11.1
modified claims 5.6.4.5
non-patentable inventions 5.4.2
noninfringement declaration applications 5.5.3, 5.6.2, 5.7.6
novelty 5.4.1.2.2, 5.4.1.2.8, 5.4.1.3, 5.4.2.1.2, 5.5.3.2
nullity proceedings 5.3.1, 5.4, 5.5.3.3, 5.6.3.1, 5.6.3.4, 5.6.5.4.2, 5.6.10, 5.7.6, 5.7.7, 5.9.2
obviousness and insufficiency 5.4.1.2.2, 5.4.1.2.6, 5.4.1.3, 5.4.2.1.3, 5.4.2.2, 5.5.3.2
oral hearings 5.4.1.2.7, 5.4.1.3, 5.4.3.2, 5.4.3.4, 5.6.4, 5.6.8, 5.6.9, 5.6.10, 5.11.1.3
overview of the patent system 5.1, 5.2, 5.3
panel/chamber system 5.6.3.2
parallel proceedings 5.4.1.2.2, 5.4.1.2.8, 5.9.2.2
parties’ overview 5.6.3.3
patent amendments 5.4.1.2
patent applications 5.1.2, 5.1.3, 5.2, 5.4.1, 5.4.2, 5.5.1
Patent Cooperation Treaty (PCT) 5.1.3
patent eligibility 5.4.2
patent infringement analysis 5.5.2
patent infringements 5.2, 5.3.1, 5.4.3.1, 5.4.3.4.4, 5.5, 5.6, 5.7, 5.9, 5.10, 5.11
patent institutions 5.1, 5.2, 5.3.1, 5.4.1.2, 6.2.1.6
patent invalidity 5.2, 5.3.1, 5.4, 5.5.3.2, 5.5.3.3, 5.6.5.4.2, 5.6.10, 5.7.6, 5.7.7, 5.9.2, 5.11.1.3
Patent Office 5.1.2, 5.2, 5.3.1, 5.4.1.2
patent revocations 5.3, 5.4, 5.11.1.3
pendency of actions 5.6.4.2
“person skilled in the art” determinations 5.4.2.1, 5.5.1, 5.5.2, 5.5.3
pharmaceutical products 5.5.3.3, 5.5.3.4, 5.11.1
plaintiff party overview 5.6.3.3
pleas 5.4.1.2.7, 5.6.1, 5.6.4.6, 5.6.6, 5.6.9, 5.9.2.4
prayers for relief (requests) 5.6.4.3, 5.6.9
pre-action protocol 5.6.2
preliminary court evaluations 5.3.2, 5.4.1.2.4, 5.4.1.2.6, 5.6.5
preliminary injunctions 5.6.5, 5.6.6.3, 5.11.1.3.2
pretrial 5.6
prior art 5.4.1.2, 5.4.1.3, 5.4.2.1, 5.4.3.2, 5.4.3.4, 5.5.1, 5.5.3.2, 5.6.5.4.2
process claims 5.5.1, 5.5.2, 5.5.3
product claims 5.5.1, 5.5.2, 5.5.3
product descriptions 5.4.2, 5.5.1, 5.5.3
protective writs 5.6.5.2
provisional terminations of injunction enforcements 5.9.1.4
public interest considerations 5.11.1
public-hearing needs 5.6.8, 5.6.9
publication/dissemination of judgments 5.7.5
punitive damages 5.7.4
“reasonable license fee” damages calculation method 5.7.4, 5.7.7
regional courts 5.3, 5.6.3.2, 5.6.4, 5.6.5, 5.6.6, 5.6.9, 5.9
removal orders 4.4
rendered accounts of third parties involved 5.7.3, 5.7.7
responding to claims 5.4.1.2.3, 5.4.1.2.5, 5.4.1.2.6, 5.4.3.4, 5.5.3, 5.6.4
right-to-use requests 5.6.2.1.2
Schengen Area 5.10
scope of claim 5.4.1.2, 5.4.2.4, 5.5.1, 5.5.3, 5.6.4.4
security bonds 5.3.1, 5.4.1.2.2.4, 5.6.5.3, 5.8.4, 5.11.1.2
seizure orders 5.6.6.3, 5.10, 5.7.2, 5.8.3, 5.10
settlements 5.4.1.2.7
specialized IP courts 5.1.1, 5.2, 5.3.1, 5.4.1
standard-essential patents (SEPs) 5.1.2
statements of case 5.4.3.4, 5.6.4, 5.6.6.1, 5.7.7
stayed injunctions pending appeal 5.9.1.4
stayed proceedings 5.3.1, 5.6.10, 5.8.4, 5.9.1.3, 5.9.1.4
subject matter of the litigation 5.4.1.2, 5.4.2, 5.5.1, 5.5.2, 5.5.3, 5.6.4.4
summonsed witnesses 5.6.7.2
technical-field inventions 5.4.2, 5.11.1
test buys 5.6.6.2
threats actions 5.4.1.2
time limits for proceedings 5.4.1.2, 5.4.3.4, 5.6.4, 5.6.5.4.3, 5.9, 5.10
United Kingdom 5.6.1
usurpation 5.4.2.3
venue, jurisdiction and case assignment rules 5.4.1.2.3, 5.4.3, 5.6.3, 5.6.9, 5.9
violation/non-compliance penalties 5.8
withdrawn claims 5.4.3.4.3, 5.6.10
witnesses 5.4.1.2.7, 5.4.1.3, 5.4.3.2, 5.6.1, 5.6.5.3, 5.6.7
written statements 5.4.1.2.5, 5.4.3.4, 5.6.1, 5.6.6, 5.6.7
see also Table of Cases and Table of Laws and Regulations
Hague Convention 5.6.4, 5.6.6.4, 9.6.2.1
Hatch-Waxman Drug Price Competition and Patent Term Restoration Act 1984 10.1.1.6, 10.6.13.5, 10.13.2, 10.15
antitrust constraints 10.13.2.1.6
case management 10.13.2.1.5
key dates 10.13.2.1.1
Paragraph IV certifications 10.13.2.1
patent infringements 10.13.2.1.4
remedies 10.13.2.1.4
“reverse payment”/”pay for delay” settlements 10.13.2.1.6
settlements 10.13.2.1.6
see also Table of Cases and Table of Laws and Regulations; United States
High Court
India 6.1.3, 6.1.4.4.4, 6.1.4.4.5, 6.2.2, 6.3.1, 6.4, 6.5, 6.6, 6.8, 6.9, 6.10.1, 6.11
Japan 7.1, 7.2.3.4, 7.1, 7.2.4.3, 7.3, 7.3.3, 7.4, 7.5.2, 7.5.3, 7.5.4, 7.6.1, 7.6.6.2, 7.7.2, 7.8
United Kingdom 9.1.1.2, 9.3.1.1–9.3.1.3, 9.4, 9.5.1, 9.6.14, 11.2.1
see also individual countries
hot-tubbing procedures
United Kingdom 9.6.13.2.4
importation prohibitions
Australia 2.10
Brazil 3.1.4, 3.5.1.1, 3.5.1.5
China 4.3.2.5.3, 4.3.2.8, 4.3.4.5
Germany 5.5.2.1, 5.6.3.3.2, 5.10
India 6.1.4.4.4, 6.5.3, 6.8.1.2
Japan 7.9
Korea (Republic of) 8.5.2.4
United States 7.9, 10.1, 10.3, 10.12.1, 10.12.2, 10.15
in camera (private) sittings
Korea (Republic of) 8.6.9
in limine motions, United States 10.6.10.1, 10.6.10.4, 10.6.13.2, 10.9, 10.12.2.10, 10.6.13.2, 10.12.2.10.3
indemnity basis, costs 2.7.4, 3.2.3.6, 9.4, 10.6.6
administrative patent review proceedings 6.1.4.4.5, 6.2, 6.9
affidavits of witnesses 6.6.7.3
alternative procedures 6.6.9
Anton Piller (“search”) orders 6.6.4, 6.7.3
appeals 6.1.3, 6.1.4.1, 6.1.4.4.4, 6.2.2, 6.3.1, 6.4, 6.9
arbitration 6.6.9
Bakshi Tekchand Committee 6.1.1
balance-of-convenience influences 6.6.4
Bolar (Roche – Bolar) exemption 6.1.4.4.4, 6.5.3
border measures 6.8.1.2
burden of proof 6.1.4.4.4, 6.6.1, 6.6.7, 6.8.2
Cell for IPR Promotion and Management 6.2.1.4
Central Government 6.1.4.4, 6.2, 6.3.2, 6.10.1
challenges to improve case management 6.1.1, 6.1.2, 6.11
challenges to patents 6.4
civil courts and judges 6.1, 6.2.2, 6.3, 6.5, 6.6, 6.7, 6.8, 6.9, 6.11
civil remedies 6.1, 6.5, 6.6.4, 6.7, 6.8.1.2, 6.11.3
claim construction 6.5.1, 6.5.2
colonization period 6.1.1
commercial courts 6.3.1.2, 6.6, 6.11.3
common law 6.6.4
compulsory licenses 6.1.1, 6.1.3, 6.1.4.2, 6.1.4.4, 6.4, 6.10.1
confidentiality issues 6.6.1, 6.6.5, 6.11.3
Controller General of Patents, Designs and Trade Marks 6.1, 6.2, 6.9, 6.11.3
Council of Scientific and Industrial Research 6.2.1.6
counterclaims 6.4, 6.5, 6.5.3, 6.5.4, 6.6.2
court-appointed scientific advisers/experts 6.6.8.3
criminal proceedings 6.3.1
cross-examination of evidence 6.6.7, 6.6.8
damages 6.1, 6.7.2, 6.8.1.2, 6.11.3
defenses 6.1.4.4.4, 6.5, 6.5.3, 6.5.4, 6.6.2, 6.6.4, 6.6.7, 6.7.2.2, 6.8.2
Department for Promotion of Industry and Internal Trade 6.2.1.2, 6.2.1.4
Department of Science and Technology 6.2.1.5
Directive Principles of State Policy in the Constitution 6.1.1
disclosures 6.5.4, 6.6.1, 6.6.5
discovery processes 6.6.5
doctrine of equivalents 6.5.1, 6.5.2
Doha Declaration 2001 6.1.4.2, 6.1.4.4.5, 6.10.1
early case management (preparatory proceedings) 6.6.3
education/training provisions 6.2.1, 6.3.2, 6.11
English law influences 6.1.1, 6.5, 6.6.4
European Community 6.1.4.1
evidence 6.2.2.2, 6.6, 6.6.7, 6.11.3
examinations 6.1.4.4, 6.2, 6.5.1, 6.6
exhaustion principle 6.1.4.2, 6.5.3
expert evidence/witnesses 6.6.5, 6.6.7, 6.6.8, 6.11.3
file wrapper rule 6.5.4, 6.6.5
General Agreement on Tariffs and Trade (GATT 1947) 6.1.1, 6.1.4
globalization period 6.1.1
High Courts 6.1.3, 6.1.4.4.4, 6.1.4.4.5, 6.2.2, 6.3.1, 6.4, 6.5, 6.6, 6.8, 6.9, 6.10.1, 6.11
historical background 6.1
hot-tubbing procedures 6.6.5, 6.6.8.4
importation prohibitions 6.1.4.4.4, 6.5.3, 6.8.1.2
injunctions 6.1, 6.6.4, 6.7, 6.8.1.2
Intellectual Property Appellate Board (IPAB) 6.1.4.4.4, 6.1.4.4.5, 6.2.2, 6.11.3
interim arrangements/deposits 6.6.4.2.2
interim injunctions 6.1, 6.6.4, 6.7
international obligations and commitments 6.1.1, 6.1.3, 6.1.4
International Preliminary Examining Authorities 6.1.4.3
inventive step 6.1.4.4
IP Division of the High Court 6.11.3
IP Nani mascot 6.2.1.4
irreparable injury conditions 6.6.4.1.3
Japan 6.1.4.4
jargon dictionary terms 6.1.4.4.3
John Doe orders 6.6.4
judges 6.3, 6.6, 6.7, 6.9, 6.11
judgments 6.2.2, 6.6.6, 6.7, 6.8
judicial institutions 6.1, 6.2.2, 6.3, 6.4, 6.9, 6.11
judicial patent proceedings 6.1, 6.2.2, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 6.10, 6.11
Justice N Rajagopala Ayyangar Committee 6.1.1, 6.1.2
lapsed patents 6.1.4.4.4
licenses 6.1.1, 6.1.3, 6.1.4.2, 6.1.4.4, 6.4, 6.6.6, 6.10.1
licenses of right 6.1.3, 6.1.4.4.4
local commissioners (LCs) 6.6.4.2, 6.6.7
Mareva (“freezing/asset-protection”) injunctions 6.6.4
national defense applications 6.1.3, 6.1.4.4.4
National Institute of Intellectual Property Management, Nagpur 6.2.1
National Intellectual Property Rights Policy 2016 6.2.1.4
National Judicial Academy (NJA) 6.3.2
non-infringement declarations 6.8.2
non-patentable inventions 6.1.3, 6.1.4.4.4, 6.1.4.4.5, 6.5.4
Norwich Pharmacal orders 6.6.4
opposition proceedings 6.1.3, 6.1.4.4.5, 6.2, 6.4, 6.5.3, 6.5.4, 6.6.8
overview of the patent system 6.1
parallel proceedings 6.4
patent applications 6.1.4, 6.1.5, 6.2
Patent Cooperation Treaty (PCT) 6.1.4
Patent Facilitation Programme 6.2.1.5
patent infringements 6.1, 6.4, 6.5, 6.6, 6.7, 6.8, 6.11
patent institutions 6.1, 6.2, 6.4, 6.5.4, 6.6.8, 6.11.3
patent invalidity 6.1.3, 6.1.4.4.5, 6.2.2.2, 6.4, 6.5.1, 6.5.3, 6.5.4, 6.6.2, 6.6.4.1, 6.6.8, 6.7.1
patent monopolies 6.1.2, 6.1.3
patent offices 6.1.3, 6.1.4, 6.2, 6.4, 6.5.4, 6.6.8
patent prosecution highways 6.1.4.4
patent revocations 6.1.3, 6.1.4.4.5, 6.4, 6.5.3, 6.5.4, 6.6.8, 6.10.1
“person skilled in the art” determinations 6.6.8.2
pharmaceutical products 6.1.1, 6.1.3, 6.1.4, 6.5.4, 6.6.4.1, 6.7.2, 6.10.1
pleas 6.6
post-grant reviews (PGRs) 6.1.4.4.5, 6.2.2.3, 6.4
post-independence period 6.1.1
pre-action mediation 6.6.9
pre-grant opposition 6.1.4.4.5, 6.2.2.2, 6.4
pretrial 6.6.5
prima facie case requirements 6.6.4
prior art 6.6.8.2
public interest considerations 6.1.3, 6.1.4.4, 6.4, 6.6.4.1
punitive damages 6.7.2.1
“purposive construction” 6.5.1
quid pro quo patent system 6.1.2
reexamination of evidence 6.6.7
search and seizure remedies 6.6.4, 6.7.3
sessions courts 6.3.1
socio-economic objectives 6.1.1, 6.1.3, 6.1.4
specialized IP courts 6.2.2
standard-essential patents (SEPs) 6.1, 6.6.4, 6.6.5, 6.6.6, 6.6.9, 6.7.2
statements of case 6.6
summary adjudication 6.6.6, 6.11.3
Supreme Court 6.1.3, 6.2.2.3.1, 6.3.1, 6.4, 6.5.1, 6.6, 6.9, 6.11
term/expiration times 6.1.3, 6.1.4
threats actions 6.8.1
time limits for proceedings 6.6.3, 6.6.4, 6.6.7, 6.11
time to trial and expedition 6.6.7, 6.11
Traditional Knowledge Digital Library (TKDL) 6.2.1.6
trials 6.6.7
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 6.1.1, 6.1.3, 6.1.4, 6.5.2, 6.6.1, 6.10.1
United Kingdom 6.1.1, 6.5, 6.6.4
venue, jurisdiction and case assignment rules 6.1.4, 6.2.2, 6.3, 6.6
World Trade Organization (WTO) 6.1.1, 6.1.4
see also Table of Cases and Table of Laws and Regulations
injunctions
Australia 2.4.2, 2.6.2, 2.6.4, 2.6.5, 2.6.10, 2.7.1, 2.8
Brazil 3.3.3, 3.7.1, 3.8, 3.12
Germany 5.1.1, 5.3.1, 5.6.2.1, 5.6.3.3, 5.6.5, 5.6.6.3, 5.7.1, 5.8, 5.9.1.4, 5.11.1.3.2
India 6.1, 6.6.4, 6.7.1, 6.8.1.2
Japan 7.6, 7.6.4, 7.7.1, 7.7.1
Korea (Republic of) 8.3.1.2, 8.3.1.3, 8.3.2, 8.5, 8.6.1, 8.6.2.1.3, 8.6.2.2.3, 8.6.6, 8.7.3
United Kingdom 9.1.1.3, 9.5.3, 9.5.5, 9.6, 9.7.1, 9.8.2, 9.9.5, 9.9.13
United States 5.9.1.4, 10.1.1.7, 10.6.7, 10.6.12, 10.6.13.6, 10.7.1, 10.10, 10.12.1.4, 10.15
see also civil remedies; interim injunctions
inter partes reviews (IPRs)
Japan 7.2.4.5.2, 7.2.4.7, 7.3.3.1, 7.4.1
Korea (Republic of) 8.2.2, 8.4.2.1, 8.4.2.5
United States 10.2.1, 10.2.2.4, 10.2.2.5, 10.2.3, 10.3.3.3, 10.4, 10.15
interim injunctions
United Kingdom 9.6, 9.9.1, 9.9.5
United States 10.6.7
see also civil remedies; injunctions
International Preliminary Examining Authorities 6.1.4.3
inventions, definitions 3.1.1, 3.1.3, 4.1.1, 4.1.3, 4.7.2, 4.7.6, 4.8, 5.4.2, 6.1.4.4.4, 7.4.5.2, 9.1.1.3, 9.5, 10.1.1.2, 10.1.1.3, 10.1.1.7, 10.5.1, 10.5.2, 11.2
inventive step
Australia 2.2.2.1, 2.2.2.3, 2.5.1, 2.6.3
Brazil 3.1.1, 3.1.2, 3.1.3.4, 3.1.3.5, 3.2.3, 3.4, 3.11.2
China 4.3.1, 4.3.2.5, 4.3.4.2, 4.7.6
Germany 5.4.1.2.2, 5.4.1.2.8, 5.4.1.3, 5.4.2.1.3
India 6.1.4.4
Japan 7.3.4, 7.4, 7.4.4, 7.4.5.2, 7.5.3
Korea (Republic of) 8.1.1, 8.5.1.1, 8.5.3.1, 8.6.3
United Kingdom 9.6.7.2
“Italian torpedo” practices, Germany 5.6.2.1.3
Japan 4.1.3.5, 6.1.4.4, 6.2.1.6, 7.1–7.9
administrative patent review proceedings 7.2, 7.3.3.1
advance notice of trial decisions 7.2.4.5.7
advisers 7.2.3, 7.2.4, 7.2.4.6, 7.3, 7.3.2.2, 7.3.3.3, 7.4, 7.6.1, 7.6.5.2, 7.6.8
alternative procedures 7.3.2.2.2, 7.6, 7.6.6.2, 7.6.8
appeals 7.1.4, 7.2, 7.3, 7.4, 7.5.2.7, 7.5, 7.6, 7.6.1, 7.6.4.6, 7.8
attorneys 7.3.3.3.3, 7.6.4, 7.6.5, 7.6.8, 7.7.2
border measures 7.9
burden of proof 7.5.2.2, 7.5.3.1, 7.6.4.1, 7.6.4.2, 7.6.5.1, 7.7.2.1
case management 7.6
certificate of contested validity 7.4.2
civil courts and judges 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
Civil Divisions of the district courts 7.6.1
civil remedies 7.3.2, 7.3.3.3.2, 7.5.3.3, 7.6, 7.6.4, 7.7
claim construction 7.2.4.1.5, 7.3.2, 7.4.5.2.2, 7.5, 7.6.7
claim terms 7.5.1
clarity defects 7.4, 7.4.5.2.6, 7.5.3.1, 7.5.3.1.7
common general knowledge (CGK) 7.4.5.2.2, 7.5.1, 7.5.3.1.4, 7.6.6.1
conciliators 7.3.2.1, 7.3.2.2, 7.6, 7.6.8
confidentiality issues 7.6.5.1
costs/expenses 7.7
court locations 7.3
cross-examination of evidence 7.2.4.1.4
Customs office 7.9
damages 7.3.2, 7.3.3.3.2, 7.5.3.3, 7.6, 7.6.4, 7.6.4.7, 7.6.7, 7.7, 7.7.2
defense of abuse of rights 7.5.3
defense of correction 7.5.3.3, 7.5.4, 7.6.3
defense of invalidity 7.2.4.5, 7.5.3, 7.5.3.2, 7.5.3.3, 7.5.4, 7.6.3, 7.6.4, 7.9
defenses 7.2.4.5, 7.4.3, 7.5, 7.5.3, 7.5.4, 7.6.2, 7.6.3, 7.6.4, 7.7.2, 7.9
destruction orders 7.6.4
direct patent infringements 7.7.1
disclosures 7.4.5.2.3, 7.5.1, 7.5.2.3, 7.6.5
discovery processes 7.6, 7.6.5
dismissed-action/revocation-of-decision statistics 7.2.4.7, 7.3.2
disposal of infringing products 7.6.4, 7.7.1
dispute resolutions 7.2.3, 7.2.4.4
district courts 7.1, 7.3, 7.5.4.3, 7.6, 7.6.4.3, 7.6.8, 7.8
doctrine of equivalents 7.2.4.6, 7.5, 7.5.2
doctrine of estoppel 7.5.2.1, 7.5.2.7
doctrine of good faith and fair dealing 7.5.3.2
documentary evidence 7.2.4.1.4, 7.4.3, 7.4.4, 7.6.2, 7.6.4.2, 7.6.5, 7.6.6
drawings 7.2.4.1.5, 7.2.4.4, 7.2.4.5.1, 7.4.5.2.7, 7.5.1.3, 7.5.3.1, 7.6.6.1
early case management (preparatory proceedings) 7.6.3
enablement requirement 7.4, 7.4.5.2.5, 7.5.3.1, 7.5.3.1.5
enforcement issues 7.5, 7.6.4.5
erga omnes effect 7.5.3.2
European Patent Convention (EPC) 7.5.1
evidence 7.2.4.1.4, 7.2.4.3, 7.2.4.6, 7.4.3, 7.4.4, 7.6.2, 7.6.3, 7.6.4, 7.6.5, 7.6.6, 7.6.7
ex parte proceedings 7.2.4.2, 7.2.4.4, 7.2.4.7, 7.3.3.1, 7.4.1, 7.4.2
Examination Guidelines 7.2.2, 7.2.4.1
examinations 7.1.2, 7.2, 7.3.3, 7.4.4, 7.6.1, 7.6.5.2
expert court officials 7.3, 7.3.2.2, 7.3.3.3, 7.4.4
expert evidence/witnesses 7.2.4.1.4, 7.6.6.1, 7.6.7
explanatory (technical briefing) sessions 7.6, 7.6.6.1
Fifth Special Division 7.1.4.1
first-to-file rule 7.1.1
formality checks 7.2.4
fraud 7.5.3
functional claims 7.5, 7.5.1.6
guideline documents 7.2.2, 7.2.3.2, 7.2.4.1, 7.2.4.2, 7.2.4.3, 7.2.4.5.1, 7.3.2.1, 7.3.3.1, 7.4.3, 7.6, 7.6.8
Hantei (advisory opinions) system 7.2.3.2, 7.2.4, 7.2.4.6, 7.4
High Court 7.1, 7.2.3.4, 7.1, 7.2.4.3, 7.3, 7.3.3, 7.4, 7.5.2, 7.5.3, 7.5.4, 7.6.1, 7.6.6.2, 7.7.2, 7.8
historical background 7.1
importation prohibitions 7.9
India 6.1.4.4
indirect patent infringements 7.7.1
infringer’s profits 7.3.3.3.2, 7.7.2, 7.7.2.2
injunctions 7.6, 7.6.4, 7.7, 7.7.1
inspections/on-site-examinations of alleged infringer’s facility 7.6.5.2
Intellectual Property High Court (IP High Court) 7.1, 7.2.3.4, 7.2.4.3, 7.2.4.5.7, 7.3, 7.3.3, 7.4, 7.5.2, 7.5.3.1, 7.6.1, 7.6.6.2, 7.7.2, 7.8
intellectual property (IP) divisions of district courts 7.1
Intellectual Property Policy Outline (2002) 7.1.4.3
inter partes reviews (IPRs) 7.2.4.5.2, 7.2.4.7, 7.3.3.1, 7.4.1
interpretation of claims 7.5.1
inventive step 7.3.4, 7.4, 7.4.4, 7.4.5.2, 7.5.3
judges 7.1.4, 7.2.3.3, 7.2.4.1.4, 7.2.4.3, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
judgments 7.1.4.3, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
judicial institutions 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
judicial patent proceedings 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7
judicial research officials 7.3, 7.3.2.2.3, 7.3.3.3.4, 7.4.4, 7.6.1, 7.6.5.2, 7.6.6.1
jury trials 7.3
key personnel 7.3, 7.3.2.2, 7.3.3.3, 7.3.4.2
languages used 7.2.2, 7.2.4.5, 7.3.3.4
licenses 7.2.4.6, 7.5.4.3, 7.6.5.1
lost-profits damages calculation method 7.7.2, 7.7.2.1
Manual for Proceedings 7.2.3.2, 7.2.4.1.3, 7.2.4.2, 7.2.4.3, 7.2.4.5.1
Meiji era (1868–1912) 7.1.1
mutatis mutandis application 7.2.4.5.1
negligence/wilfulness tort claims 7.7.2
non-patentable inventions 7.2.4.5.1
novelty 7.4, 7.4.4, 7.4.5.2, 7.5.3.1, 7.5.3.1.2
obviousness 7.5.3
opposition proceedings 7.2.3, 7.2.4, 7.2.4.3, 7.2.4.4
orders to produce documents 7.6.5
overturned trial/appeal decisions by the IP High Court 7.4.4
overview of the patent system 7.1, 7.2, 7.4.1, 7.6
panel system 7.1.4.1, 7.2.4, 7.3.3.3.2, 7.5.2.2, 7.5.3.1, 7.6, 7.7.2, 7.8
parallel JPO invalidation trials 7.5.3, 7.5.3.2, 7.9
patent amendments 7.2.3, 7.2.4, 7.3.3.1, 7.4, 7.4.5.2.7, 7.5.3.1
patent applications 7.1, 7.2, 7.3.3, 7.4.5.2.2, 7.5.1
Patent Cooperation Treaty (PCT) 7.1
patent infringement determination 7.6, 7.6.6, 7.7
patent infringements 7.2.4.5, 7.2.4.6, 7.3.2, 7.5, 7.6, 7.7, 7.8, 7.9
patent institutions 6.1.4.4, 6.2.1.6, 7.1, 7.2, 7.3.3, 7.4, 7.6.4.1
patent invalidity 7.2.3, 7.2.4, 7.3.3, 7.3.4, 7.4, 7.5, 7.5.3, 7.6, 7.9
patent revocations 7.2.3.4, 7.2.4.3, 7.2.4.4, 7.3.2, 7.3.3, 7.4
preliminary injunctions 7.6, 7.6.4
preliminary view on infringement and settlement 7.6, 7.6.6.2
prior art 7.2.4.1.5, 7.2.4.3, 7.3.4, 7.4.4, 7.4.5.2.2, 7.5.1.3, 7.5.2.3, 7.5.3.1, 7.5.3.1.4, 7.6.3, 7.6.6
procedural defects 7.4.5
product descriptions 7.2.4.1.5, 7.2.4.4, 7.2.4.5.1, 7.4, 7.4.5.2.4, 7.5.1, 7.5.2, 7.5.3.1, 7.6.3, 7.6.6
product-by-process claims 7.2.4.5.2, 7.4.5.2.6, 7.5, 7.5.1.5
public interest considerations 7.2.4.3
punitive damages 7.7.2
reasonable royalties 7.7.2, 7.7.2.1, 7.7.2.3, 7.7.2.4
Regional Comprehensive Economic Partnership 4.1.3.5
rejected/refused patent applications 7.2.2, 7.2.3, 7.2.4.2
reputation/credibility civil remedies 7.6.4, 7.7.3
res judicata judgments 7.4.6
responding to claims 7.2.4.5, 7.4.3, 7.6
retrial assertion limitations 7.5.3.3
review of JPO decisions by the IP High Court 7.4
royalties 7.7.2, 7.7.2.1, 7.7.2.3, 7.7.2.4
scope of claim 7.2.3, 7.2.4, 7.2.4.5, 7.2.4.6, 7.4, 7.4.5.2, 7.5.1, 7.5.2, 7.5.3.1, 7.6.3, 7.6.6
security deposits 7.6.4.4
Sixth Special Division 7.1.4.1
specialized IP courts 7.1.4, 7.3
standard-essential patents 7.2.4.6
statements of case 7.2.4.5.1, 7.6.2, 7.6.7
substantive law defects 7.4.5.2
support requirement 7.4, 7.4.5.2.4, 7.5.3.1, 7.5.3.1.6
Supreme Court 7.1.4, 7.3, 7.3.4, 7.4, 7.5, 7.6.1, 7.8
time limits for proceedings 7.2.4.2, 7.2.4.4, 7.4.3, 7.5.4.2, 7.6.4.6, 7.7.3.2
tort law 7.7.2
Trial and Appeal department of the JPO (TAD) 7.1.2, 7.2, 7.3.3, 7.4.2, 7.4.4
trial for correction 7.2.3.2, 7.2.3.4, 7.2.4.4, 7.2.4.5, 7.3.3.1, 7.4, 7.4.5.2.7, 7.5.4
trial for invalidation 7.2.3.2, 7.2.3.4, 7.2.4.1.4, 7.2.4.4, 7.2.4.5, 7.3.3.1, 7.4, 7.6.4
two-stage district court infringement/damages assessments 7.6
unjust-enrichment returns 7.7.3.2
utility model patents 7.1.2, 7.2.2, 7.3.3.1
venue, jurisdiction and case assignment rules 7.3, 7.6
videoconferences 7.2.4.1.4
witnesses 7.2.4.1.4, 7.6.4.2, 7.6.7
see also Table of Cases and Table of Laws and Regulations
Japan Patent Office (JPO) 6.1.4.4, 6.2.1.6, 7.1, 7.2, 7.3, 7.3.3, 7.4, 7.5.2.1, 7.5.2.7, 7.5.3, 7.5.4, 7.6.4.1
John Doe orders, India 6.6.4
judges
Australia 2.3, 2.4, 2.5.1, 2.6, 2.7, 2.9
Brazil 3.3, 3.4, 3.6, 3.7, 3.12
China 4.1.3, 4.1.4, 4.1.5, 4.2, 4.3, 4.6, 4.7, 4.8, 4.9
Germany 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9
India 6.3, 6.6, 6.7, 6.9, 6.11
Japan 7.1.4, 7.2.3.3, 7.2.4.1.4, 7.2.4.3, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
Korea (Republic of) 8.2.2, 8.3.1, 8.3.2, 8.4.2.6, 8.4.2.10, 8.5, 8.6, 8.8, 8.9
United Kingdom 9.1.1, 9.2, 9.3, 9.6, 9.6.14, 9.7, 9.8
United States 5.6.2.1, 10.1.1, 10.2.1, 10.2.2.4, 10.2.3, 10.3, 10.6, 10.10, 10.12.2, 10.13.2.1, 10.14, 10.15
judgments
Australia 2.6.4, 2.6.6, 2.7, 2.8, 2.9
Boards of Appeal of the European Patent Office (EPO) 11.6.9
Brazil 3.2.4, 3.3, 3.7, 3.8, 3.9
China 4.1.3, 4.1.4, 4.3.2, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
Germany 5.3.1, 5.4.1, 5.4.2.1.2, 5.4.3.1, 5.4.3.2, 5.4.3.4, 5.6.2, 5.6.9, 5.6.10, 5.7, 5.8, 5.9
Japan 7.1.4.3, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
Korea (Republic of) 8.2.2, 8.3.1, 8.4.2.10, 8.5.3.1, 8.6.11, 8.8
United Kingdom 9.6.14–9.6.15, 9.7, 9.8.3, 9.9.5, 9.9.10
United States 10.2.2, 10.2.3, 10.6.6, 10.6.9, 10.6.10, 10.6.13.3, 10.6.13.4, 10.9, 10.12.2, 10.12.2.9, 10.12.2.11.4, 10.13.2.1, 10.15
see also appeals; Table of Cases and Table of Laws and Regulations
judicial institutions
Brazil 3.1.1, 3.2.4, 3.3, 3.4, 3.6, 3.9, 3.11, 3.12
China 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
European Patent Office (EPO) 10.2.1, 11.2–11.6
Germany 5.1, 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.10, 5.11
India 6.1, 6.2.2, 6.3, 6.4, 6.9, 6.11
Japan 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7, 7.8
Korea (Republic of) 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8
United Kingdom 9.1, 9.3, 9.5, 9.8
United States 10.1, 10.2, 10.3, 10.4, 10.5, 10.6.3, 10.10, 10.12, 10.14, 10.15
judicial patent proceedings
Australia 2.1.1, 2.2, 2.3, 2.6, 2.7, 2.8, 2.10
Brazil 3.1.1, 3.1.2, 3.1.4, 3.2.4, 3.3, 3.4, 3.6, 3.11, 3.12
China 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9
European Patent Office (EPO) 10.2.1, 11.2–11.6
Germany 5.1, 5.2, 5.3, 5.4, 5.6, 5.7, 5.8, 5.9, 5.10, 5.11
India 6.1, 6.2.2, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 6.10, 6.11
Japan 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7
Korea (Republic of) 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8
remote-trial videoconferencing techniques 2.6.3, 2.6.10, 4.1.5, 4.6, 5.6.9, 6.6.7, 7.2.4.1.4, 9.6.13, 9.9.1.3, 9.9.5.1, 9.9.9, 11.6.2, 11.6.8.1, 11.6.8.4
United Kingdom 5.6.1, 9.1, 9.2, 9.3, 9.4, 9.5, 9.6, 9.7–9.8
United States 5.6.1, 5.6.3.3, 10.1, 10.2, 10.3, 10.4, 10.5, 10.6, 10.10, 10.12, 10.13, 10.14, 10.15
jury trials
Japan 7.3
Korea (Republic of) 8.3.1.1
United States 10.3.2, 10.6, 10.6.10.2, 10.6.13, 10.13.2.1.4, 10.15
see also trials
Korea (Republic of) 3.1.6, 4.1.3.5, 8.1–8.9
abuse of rights 8.5.3
adjudications 8.4.2
administrative litigation 8.3.1.3, 8.4.2, 8.6.9
administrative patent review proceedings 8.2, 8.3.1.1, 8.4.1
Advanced Institute of Science and Technology 8.3.1.4
affidavits of witnesses 8.4.2.6, 8.6.6
alternative dispute resolution (ADR) 8.6.11
appeals 8.1.1, 8.2, 8.3.1, 8.3.2, 8.4.1.2, 8.4.2.2, 8.4.2.9, 8.4.2.10, 8.6.2, 8.6.6, 8.8, 8.9.2.3, 8.9.6
attorneys 8.3.2.3, 8.4.2.6, 8.6
bankruptcy issues 8.3.1.1
bifurcation (separate trials) ground rules 8.3.1.3
burden of proof 8.5.2.4, 8.5.3, 8.6.1
case management 8.6.4
certificate of contested validity 8.2.2
China 4.1.3.5
civil courts and judges 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8, 8.9
civil remedies 8.3.1.2, 8.3.2, 8.5, 8.6, 8.7
claim construction 8.3.2, 8.4.2, 8.5.1, 8.7.3.2
compulsory licenses 8.5.3.5
confidentiality issues 8.6.7.6.2.2, 8.6.9, 8.9
court-appointed scientific advisers/experts 8.6.5, 8.6.7, 8.6.8
criminal proceedings 8.3.1, 8.3.2.1, 8.5, 8.6.9.2, 8.6.11, 8.9
damages 8.5, 8.6.1, 8.6.2.2.2, 8.6.3, 8.7, 8.7.4
defenses 8.5.2, 8.5.3, 8.6, 8.7.3
destruction orders 8.7.3
direct patent infringements 8.5, 8.9
disclosures 8.6.7, 8.6.9, 8.6.11, 8.7.3
district courts 8.2, 8.3, 8.6, 8.8, 8.9
doctrine of equivalents 8.5.2.3, 8.9.4.1
document submission orders 8.6.7.4, 8.6.9.3
documentary evidence 8.6.7, 8.6.9
drawings 8.5.1.2, 8.6.3, 8.6.8
early case management (preparatory proceedings) 8.6.4
education/training provisions 8.3.2.3, 8.3.3, 8.4.2.6, 8.6.8
Electronic Case Filing System (ECFS) 8.6.1.2
employee inventions 8.6.1, 8.7
enforcement of concentrated jurisdiction 8.3.1.3
English law influences 8.3.1.1
enhanced/additional damages 8.7.4.2.6
evidence 8.2.2.2, 8.4.2, 8.5.1, 8.6, 8.8
evidence preservation orders 8.6.7.5
ex parte proceedings 8.2.2, 8.4.2.3, 8.4.2.5
examinations 8.3.1.4, 8.4.1, 8.4.2.5, 8.4.2.7, 8.6
exhaustion principle 8.5.3.4
experiments 8.7.2
expert evidence/witnesses 8.4.2.6, 8.6.5, 8.6.7, 8.9
first-sale exhaustion doctrine 8.5.3.4
first-to-file rule 8.5.3.1
fraud 8.9
free-to-exploit technology 8.5.2.3, 8.5.3.2, 8.5.3.3
goodwill/reputation civil remedies 8.7
hearings 8.2.2, 8.4.2.6, 8.4.2.7, 8.6.1, 8.6.3, 8.6.5, 8.6.6, 8.6.7, 8.6.10, 8.6.11, 8.8, 8.9.4, 8.6, 8.6.10, 8.9.4
importation prohibitions 8.5.2.4
imprisonment for patent infringements 8.9, 8.9.2, 8.9.5
in camera (private) reviews 8.6.9
indirect patent infringements 8.5.2.4, 8.9.4.1
injunctions 8.3.1.2, 8.3.1.3, 8.3.2, 8.5, 8.6.1, 8.6.2.1.3, 8.6.2.2.3, 8.6.6, 8.7
Intellectual Property Trial and Appeal Board (IPTAB) 8.2, 8.3.1, 8.4.1, 8.4.2, 8.5.3.1, 8.8.1, 8.9
inter partes proceedings 8.2.2, 8.4.2.1, 8.4.2.5
international divisions 8.3.2.2
inventive step 8.1.1, 8.5.1.1, 8.5.3.1, 8.6.3
judges 8.2.2, 8.3.1, 8.3.2, 8.4.2.6, 8.4.2.10, 8.5, 8.6, 8.8, 8.9
judgments 8.2.2, 8.3.1, 8.4.2.10, 8.5.3.1, 8.6.11
judicial institutions 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8
judicial patent proceedings 8.1, 8.2, 8.3, 8.4, 8.5, 8.6, 8.8
Judicial Research and Training Institute 8.3.3
jurisdiction by court level 8.6.2.3, 8.9.2.3
jury trials 8.3.1.1
known technologies 8.5.2.3, 8.5.3.2, 8.5.3.3
litigation procedures for revocation suits 8.4.2.6
lost-profits damages calculation method 8.7.4.2
material submission orders 8.6.7.4.2, 8.6.9.3
mediation 8.6.11
mutatis mutandis application 8.4.1, 8.4.2.1
negligence/wilfulness tort claims 8.7.4
non bis in idem principle 8.2.2.2
nonexclusive licenses 8.5
opposition proceedings 8.2.2, 8.4.2, 8.5.3, 8.6
parallel examinations 8.4.2.7
patent amendments 8.2, 8.5.3.1
patent applications 3.1.6, 8.1, 8.2, 8.4.1, 8.4.2, 8.5.1
Patent Bureau Appellate Tribunal 8.1.1, 8.2, 8.3.1.4
Patent Bureau Tribunal 8.1.1, 8.2, 8.3.1.4
patent case types 8.3.1.2
Patent Court 8.1, 8.2, 8.3.1, 8.3.2, 8.4.1, 8.4.2, 8.6.2, 8.6.11.3.4, 8.8, 8.9.3.2
patent infringements 8.1, 8.3.1, 8.4.2.6.6, 8.4.2.7, 8.5, 8.6, 8.7, 8.9
patent institutions 8.1, 8.2, 8.3.1.4, 8.4.1, 8.4.2, 8.5.1, 8.8
patent invalidity 8.1, 8.2, 8.3.1, 8.4, 8.5.1, 8.5.3, 8.6.3
patent monopolies 8.5
patent revocations 8.2, 8.3.1, 8.3.2, 8.4
permanent injunctions 8.7.3
police officers 8.9.3
preliminary injunctions 8.3.1.3, 8.3.2, 8.6.1, 8.6.2.1.3, 8.6.6
preparatory proceedings 8.4.2.6.3, 8.6.4, 8.6.5
pretrial 8.6.11
prior art 8.4.2.6.4, 8.5.2.3, 8.5.3, 8.6.3
product descriptions 8.5.1.2, 8.5.2, 8.5.3, 8.6.3, 8.6.8
prosecutors’ office 8.9.3
reasonable royalties 8.6.1, 8.6.2, 8.6.7.6, 8.7.2, 8.7.4.2
reduced damages 8.7.4.2.4
reexamination procedures 8.2.2
Regional Comprehensive Economic Partnership 4.1.3.5
responding to claims 8.4.2.6, 8.5.2, 8.5.3, 8.6
royalties 8.6.1, 8.6.2, 8.6.7.6, 8.7.2, 8.7.4.2
scope-of-protection/claims relationship 8.5.1, 8.5.2, 8.6.1, 8.9.4.1
search and seizure remedies 8.7.3, 8.9.5
sentences for patent infringements 8.9.5
settlements 8.6.11
specialized IP judiciary 8.3.2
specialized patent judges 8.3.2.3
statements of case 8.5.2, 8.6.3
subject matter jurisdiction 8.6.2.2, 8.9.2
Supreme Court 8.1, 8.2.2.1, 8.3, 8.4.1.2, 8.4.2.1, 8.4.2.5, 8.4.2.9, 8.5.3, 8.6.2.3, 8.6.11, 8.7.2, 8.8.2, 8.9.2.3, 8.9.4, 8.9.6
term/expiration times 3.1.6, 8.6.1
territorial jurisdiction 8.6.2.1, 8.9.2, 8.9.3
time limits for proceedings 8.2.2, 8.4.2, 8.6
tort law 8.7.4
trade secrets 8.6.7.4.2, 8.6.9
transferred cases 8.6.2.1.2, 8.9.3.4
trials 8.2, 8.3, 8.4.2, 8.6, 8.9.4
United Kingdom 8.3.1.1
United States 8.1, 8.4.2, 8.6.1, 8.6.7
utility 8.6.7.4, 8.6.7.6.2, 8.7.2
venue, jurisdiction and case assignment rules 8.2.2, 8.3.1, 8.4.1, 8.6.2
video files 8.6.8
witnesses 8.4.2.6, 8.6.5, 8.6.6, 8.6.7, 8.9
see also Table of Cases and Table of Laws and Regulations
Korea Trade Commission 8.4.2
Korean Intellectual Property Office (KIPO) (formerly the Patent Bureau) 8.1, 8.2, 8.3.1.4, 8.4.2, 8.5.1, 8.6.7.6.2, 8.9.3
languages used
Boards of Appeal of the European Patent Office (EPO) 11.6.8.3
Brazil 3.2.2
China 4.3.1.7
EPO official languages (English, German, French) 11.6.8.3
Germany 5.4.1.2, 5.6.4.3, 5.6.9
Korea (Republic of) 8.3.2.2, 8.6.8
lawyers
see also attorneys; barristers and solicitors
listing of cases, Boards of Appeal of the European Patent Office (EPO) 11.6.5.4
Locarno Agreement establishing an International Classification for Industrial Designs 4.1.3.5
lost-sales damages calculation method
Australia 2.7.2.1
Germany 5.7.4
see also civil remedies; damages
Lugano Convention 5.6.3.1, 9.6.2
Mareva (“freezing/asset-protection”) injunctions
Australia 2.7.3
India 6.6.4
Markman hearings
Germany 5.6.1
United States 5.6.1, 6.5.1, 10.5.1, 10.6.1, 10.6.6.1, 10.12.2.8
mediators
Japan 7.6.8
Korea (Republic of) 8.6.11
United Kingdom 9.6.17
United States 10.6.4
see also arbitration
mutatis mutandis application
Japan 7.2.4.5.1
Korea (Republic of) 8.4.1, 8.4.2.1
national defense applications
see also public interest
non bis in idem principle, Korea (Republic of) 8.2.2.2
Northern-Ireland jurisdiction 9.1.1.2, 9.3.1.5, 9.5.1
see also United Kingdom
novelty
Australia 2.2.2.1, 2.6.3, 2.6.7
Brazil 3.1.1, 3.1.2, 3.1.3.4, 3.1.3.5, 3.2.3.1, 3.4, 3.11.2
China 4.1.1.2, 4.1.3.4, 4.3.1, 4.3.2.5.4, 4.3.4.2, 4.7.5
definitions 4.7.5
European Patent Office (EPO) 5.4.2.1.2, 11.2, 11.4
Germany 5.4.1.2.2, 5.4.1.2.8, 5.4.1.3, 5.4.2.1.2, 5.5.3.2
Japan 7.4, 7.4.4, 7.4.5.2, 7.5.3.1, 7.5.3.1.2
Korea (Republic of) 8.5.1.1, 8.5.3.1
United Kingdom 9.6.3, 9.6.14, 9.7.4, 9.9.4
United States 10.2.1
obviousness and insufficiency
Australia 2.2.2.1, 2.2.2.3, 2.5.1, 2.6.7
Brazil 3.1.3.5
Germany 5.4.1.2.2, 5.4.1.2.6, 5.4.1.3, 5.4.2.1.3, 5.4.2.2, 5.5.3.2
Japan 7.5.3
United Kingdom 9.6.7.2, 9.6.13.2.2, 9.6.14, 9.7.4
United States 10.1.1.2, 10.1.1.3, 10.1.1.7, 10.2.1
official languages (English, German, French), European Patent Office (EPO) 11.6.8.3
opposition proceedings
Australia 2.2
European Patent Office (EPO) 10.2.1, 11.2, 11.4, 11.6.4, 11.6.10
India 6.1.3, 6.1.4.4.5, 6.2, 6.4, 6.5.3, 6.5.4, 6.6.8
Japan 7.2.3, 7.2.4, 7.2.4.3, 7.2.4.4
Korea (Republic of) 8.2.2, 8.4.2, 8.5.3, 8.6
see also defenses; patent invalidity
parallel proceedings
Germany 5.4.1.2.2, 5.4.1.2.8, 5.9.2.2
India 6.4
United States 10.3.2, 10.12.2, 10.12.5.1, 10.14, 10.15
Paris Convention for the Protection of Industrial Property 2.2.1, 3.1.1, 3.1.6, 3.2.1, 3.2.3.3, 3.11.2.3, 4.1.3.5, 6.1.4, 7.1.1, 11.1
see also European Patent Convention
patent amendments
Boards of Appeal of the European Patent Office (EPO) 11.4, 11.6
Brazil 3.2.3.8
Germany 5.4.1.2
Japan 7.2.3, 7.2.4, 7.3.3.1, 7.4, 7.4.5.2.7, 7.5.3.1
Korea (Republic of) 8.2, 8.5.3.1
United States 10.2.1, 10.2.2.4
patent applications
Brazil 3.1.1, 3.1.2, 3.1.3, 3.1.4, 3.1.7, 3.2.2, 3.2.3, 3.2.4, 3.11.2
China 3.1.6, 4.1.2, 4.3.1, 4.3.2.4, 4.3.2.7, 4.5.2, 4.7, 4.8, 7.1.3, 7.2
European Patent Office (EPO) 5.1.2, 5.4.2, 7.5.1.1, 11.1.2
Germany 5.1.2, 5.1.3, 5.2, 5.4.1, 5.4.2, 5.5.1
Japan 7.1.3, 7.2, 7.3.3, 7.4.5.2.2, 7.5.1
Korea (Republic of) 3.1.6, 8.1.2, 8.2, 8.4.1, 8.4.2, 8.5.1
United States 3.1.6, 7.1.3, 7.2, 7.5.1.1, 10.2.1, 10.3.3
Patent Cooperation Treaty (PCT) 2.1.2, 2.2.1, 3.1.7, 3.2.1, 3.2.3.3, 4.1.1.2, 4.1.2, 4.1.3.5, 5.1.3, 6.1.4, 6.1.5, 7.1, 8.1.2, 9.1.2, 9.1.1.3, 10.2.1, 11.1
definition 6.1.4
national phase entries 2.1.2, 3.1.7, 4.1.2, 5.1.3, 6.1.5, 7.1.3, 8.1.2, 9.1.2, 10.2.1, 11.1
see also European Patent Convention
patent infringements
Australia 2.2.1, 2.2.2.2, 2.3, 2.4, 2.5, 2.6.1, 2.6.2, 2.6.3, 2.6.4, 2.6.5, 2.6.7, 2.7, 2.8
Boards of Appeal of the European Patent Office (EPO) 11.3.3, 11.5, 11.6.2.1, 11.6.5.2
Brazil 3.1.1, 3.1.4, 3.3, 3.4, 3.5, 3.6, 3.7
China 4.1.1.2, 4.1.3, 4.1.5, 4.2.1, 4.2.3.2, 4.3, 4.4, 4.5, 4.6, 4.8, 4.9
definitions 2.5.1, 3.3.3, 3.5, 4.3.2, 4.3.3, 5.5, 6.4, 6.5.2, 8.4.2.6.6, 8.5, 8.7.3, 8.9.4.1, 9.5, 10.1.1.2, 10.5.1, 10.5.2, 10.9
Germany 5.2, 5.3.1, 5.4.3.1, 5.4.3.4.4, 5.5, 5.6, 5.7, 5.9, 5.10, 5.11
India 6.1, 6.4, 6.5, 6.6, 6.7, 6.8, 6.11
Japan 7.2.4.5, 7.2.4.6, 7.3.2, 7.5, 7.6, 7.7, 7.8, 7.9
Korea (Republic of) 8.1, 8.3.1, 8.4.2.6.6, 8.4.2.7, 8.5, 8.6, 8.7, 8.9
noninfringement declaration applications 2.8.1, 4.5.1, 5.5.3, 5.6.2, 5.7.6,
United Kingdom 6.5.1, 9.1.1.2, 9.1.1.3, 9.2, 9.3.1.2, 9.4, 9.5, 9.6, 9.7, 9.8
United States 7.9, 10.1, 10.2.1, 10.3, 10.4, 10.5, 10.6, 10.7, 10.9, 10.12, 10.13, 10.15
patent institutions
Australia 2.2
Brazil 3.1.1, 3.1.3.4, 3.2, 3.4, 3.6.1, 3.11
China 4.1, 4.2, 4.3.2.4, 4.3.2.7, 4.5.5, 4.7, 4.8, 7.2
European Patent Office (EPO) 5.1.2, 6.2.1.6, 9.1.1.2, 9.1.1.3, 9.4, 10.2.1, 11.1–11.6
Germany 5.1, 5.2, 5.3.1, 5.4.1.2, 6.2.1.6
India 6.1, 6.2, 6.4, 6.5.4, 6.6.8, 6.11.3
Japan 6.1.4.4, 6.2.1.6, 7.1, 7.2, 7.3.3, 7.4, 7.6.4.1
Korea (Republic of) 8.1, 8.2, 8.3.1.4, 8.4.1, 8.4.2, 8.5.1, 8.8
United Kingdom 5.1.2, 6.2.1.6, 9.1.1, 9.2, 9.6, 9.7.3
United States 6.2.1.6, 7.2, 10.1, 10.2, 10.3, 10.6.10.2, 10.15
patent invalidity
Australia 2.2, 2.3, 2.4, 2.5.1.3, 2.6.2, 2.6.3, 2.6.6.3, 2.6.7, 2.9
Boards of Appeal of the European Patent Office (EPO) 10.2.1, 11.3.3, 11.4
Brazil 3.1.1, 3.1.2, 3.1.3, 3.2.3.8, 3.2.4, 3.3, 3.4, 3.5.2, 3.6, 3.8.2
China 4.1.1, 4.1.3.4, 4.1.5, 4.2.1, 4.3.1.7, 4.3.2.7, 4.3.4, 4.4.2.3, 4.5.5.3.2, 4.7, 4.8
definitions 2.4, 2.6.6.3, 3.1.1, 3.3.3, 5.4.2, 6.4, 6.5.4, 7.4.5, 7.5.3, 8.5.3, 9.4, 10.1.1.2, 11.3.3, 11.4
Germany 5.2, 5.3.1, 5.4, 5.5.3.2, 5.5.3.3, 5.6.5.4.2, 5.6.10, 5.7.6, 5.7.7, 5.9.2, 5.11.1.3
India 6.1.3, 6.1.4.4.5, 6.2.2.2, 6.4, 6.5.1, 6.5.3, 6.5.4, 6.6.2, 6.6.4.1, 6.6.8, 6.7.1
Japan 7.2.3, 7.2.4, 7.3.3, 7.3.4, 7.4, 7.5, 7.5.3, 7.6, 7.9
Korea (Republic of) 8.1, 8.2, 8.3.1, 8.4, 8.5.1, 8.5.3, 8.6.3
United Kingdom 9.1.1.3, 9.2, 9.3.2, 9.4, 9.6.3, 9.6.7.2, 9.6.13.2.1, 9.7.3–9.7.4, 9.9.4
United States 10.1, 10.2.1, 10.2.2, 10.3, 10.4, 10.5.3, 10.6.5, 10.6.6, 10.6.7, 10.7.1, 10.13.2.1, 10.15
see also defenses; inventive step; novelty; patent revocations; prior art
Patent Law Treaty 3 3.4
patent monopolies
Australia 2.5.1
Brazil 3.1.1
Korea (Republic of) 8.5
United Kingdom 2.1.1, 9.7.1, 10.1.1
United States 10.1.1.2, 10.1.1.3
Patent Office
Brazil 3.2
Germany 5.1, 5.2, 5.3.1, 5.4.1.2
India 6.1.3, 6.1.4, 6.2, 6.4, 6.5.4, 6.6.8
Japan 6.1.4.4, 6.2.1.6, 7.1, 7.2, 7.3, 7.3.3, 7.4, 7.5.2.1, 7.5.2.7, 7.5.3, 7.5.4, 7.6.4.1
United Kingdom (UKIPO) 6.2.1.6, 9.1.1.2, 9.2, 9.6.2, 9.6.6, 9.7.3
United States 6.2.1.6, 7.2, 10.1, 10.2, 10.6.12, 10.15
patent revocations
Australia 2.2.2.1.3, 2.2.2.4, 2.3, 2.4, 2.6.1, 2.6.2, 2.6.3, 2.6.7, 2.7.3
Brazil 3.9.1, 3.9.2, 3.11.1.3.5
European Patent Office (EPO) 5.4.1.2.6, 5.4.2, 10.2.1, 11.2, 11.3.3, 11.6.4, 11.6.9
India 6.1.3, 6.1.4.4.5, 6.4, 6.5.3, 6.5.4, 6.6.8, 6.10.1
Japan 7.2.3.4, 7.2.4.3, 7.2.4.4, 7.3.2, 7.3.3, 7.4
Korea (Republic of) 8.2, 8.3.1, 8.3.2, 8.4
United Kingdom 9.3.1.2, 9.4, 9.5.5, 9.6.3, 9.7.3
see also patent invalidity
patent system overviews
Australia 2.1
India 6.1
Korea (Republic of) 8.1, 8.3.1
United Kingdom 9.1
United States 10.1, 10.3, 10.12, 10.15
People’s Republic of China see China
pharmaceutical products
Australia 2.6.4
China 4.1.1.2, 4.1.3.3, 4.2.3.2.3, 4.3.2.5.5, 4.3.4.5, 4.5.4.1, 4.5.5, 4.7.2.2.3, 4.7.9.1
Germany 5.5.3.3, 5.5.3.4, 5.11.1
India 6.1.1, 6.1.3, 6.1.4, 6.5.4, 6.6.4.1, 6.7.2, 6.10.1
United States 10.1.1.6, 10.3, 10.6.13.5, 10.13.2
see also compulsory licenses
post-grant reviews (PGRs)
United States 10.2.1, 10.2.2.5, 10.3.3.3
pre-action protocol
Australia 2.6.5.5
Germany 5.6.2
India 6.6.9
United Kingdom 9.6.1, 9.9.2, 9.9.4
United States 10.6.2
President, European Patent Office (EPO) 11.2, 11.3
pretrial
Brazil 3.6.3
Germany 5.6
India 6.6.5
Korea (Republic of) 8.6.11
United Kingdom 9.6.11, 9.6.13, 9.6.14, 9.9.8
United States 10.6.2, 10.6.4, 10.6.6.1, 10.6.9.2, 10.6.10, 10.6.13
see also case management; claim construction
prior art
Australia 2.2.1, 2.2.2.3, 2.5.1, 2.6.3, 2.6.6.3, 2.6.7
Brazil 3.1.3.4, 3.1.3.5, 3.2.3.1, 3.2.4
China 4.1.1.2, 4.3.2, 4.3.4.1, 4.5.5.3.2, 4.7.5, 4.7.6, 4.7.9, 4.8.2.2, 4.8.3, 4.8.5, 4.8.6, 4.8.9
Germany 5.4.1.2, 5.4.1.3, 5.4.2.1, 5.4.3.2, 5.4.3.4, 5.5.1, 5.5.3.2, 5.6.5.4.2
India 6.6.8.2
Japan 7.2.4.1.5, 7.2.4.3, 7.3.4, 7.4.4, 7.4.5.2.2, 7.5.1.3, 7.5.2.3, 7.5.3.1, 7.5.3.1.4, 7.6.3, 7.6.6
Korea (Republic of) 8.4.2.6.4, 8.5.2.3, 8.5.3, 8.6.3
United Kingdom 9.3.2, 9.6.3, 9.6.6, 9.6.8, 9.9.4
United States 10.2.1, 10.2.2, 10.6.6, 10.6.7, 10.6.10.4, 10.12.2.10.3
public interest considerations
Australia 2.10
Brazil 3.2.3.5, 3.2.3.6, 3.6.6, 3.11.2
China 4.1.1.2, 4.1.4, 4.3.1.2, 4.4.3.3, 4.5.5, 4.7.2, 4.7.5.3, 4.7.12.1.2, 4.8.2.2
Germany 5.11.1
India 6.1.3, 6.1.4.4, 6.4, 6.6.4.1
Japan 7.2.4.3
United Kingdom 9.7.1
United States 10.10.1, 10.12.2.5, 10.15
“purposive construction”
India 6.5.1
United Kingdom 9.5.2
ratio decindendi system, United Kingdom 9.1.1.2–3
“reasonable license fee” damages calculation method
Australia 2.7.2.1
reasonable royalties
definitions 8.7.4.2.3
Japan 7.7.2, 7.7.2.1, 7.7.2.3, 7.7.2.4
Korea (Republic of) 8.6.1, 8.6.2, 8.6.7.6, 8.7.2, 8.7.4.2
United States 10.1.1.7, 10.6.10, 10.7.2, 10.7.2.2, 10.10.1.1, 10.13.2.2.2
reference product sponsors (RPSs), biosimilar products 10.13.2.2, 10.15
Regional Comprehensive Economic Partnership 4.1.3.5
remedies see civil remedies
remote-trial videoconferencing techniques 2.6.3, 2.6.10, 4.1.5, 4.6, 6.6.7, 5.6.9, 7.2.4.1.4, 9.6.13, 9.9.1.3, 9.9.5.1, 9.9.9, 11.6.2, 11.6.8.1, 11.6.8.4
Republic of Korea see Korea (Republic of)
res judicata judgments
Japan 7.4.6
United States International Trade Commission (USITC) 10.12.5.2.3
Schengen Area 5.10
Scotland jurisdiction 9.1.1.2, 9.3.1.4, 9.5.1
see also United Kingdom
specialized IP judiciary 3.3.2, 4.1.5, 7.3.1, 8.3.1, 9.9, 10.3.2, 11.3.2
squeezes on the patentee 9.3.2, 9.6.13.2.1
standard-essential patents (SEPs)
China 4.5.4
Germany 5.1.2
India 6.1, 6.6.4, 6.6.5, 6.6.6, 6.6.9, 6.7.2
United States 10.13.1
stare decisis system, United Kingdom 9.1.1.2
statements of case
Boards of Appeal of the European Patent Office (EPO) 11.6.3, 11.6.4
Brazil 3.6.2
Germany 5.4.3.4, 5.6.4, 5.6.6.1, 5.7.7
India 6.6
Korea (Republic of) 8.5.2, 8.6.3
United Kingdom 9.6.3, 9.6.4, 9.9.4
United States 10.5, 10.6.2, 10.6.5, 10.12.2.10
Statistics and Trends Centre, European Patent Office (EPO) 11.1.2
stayed injunctions pending appeal
Germany 5.9.1.4
United States 5.9.1.4, 10.10.1.1
stayed proceedings
Germany 5.3.1, 5.6.10, 5.9.1.3, 5.9.1.4
United States 5.9.1.4, 10.3, 10.12.2.4, 10.12.5, 10.13.2.1.4
Story, Joseph 10.1.1.2
Strasbourg Agreement concerning the International Patent Classification 4.1.3.5
Supreme Court
China 4.1.3.1, 4.1.3.3, 4.1.4, 4.1.5, 4.2, 4.3
Germany 5.4.2
India 6.1.3, 6.2.2.3.1, 6.3.1, 6.4, 6.5.1, 6.6, 6.9, 6.11
Japan 7.1.4, 7.3, 7.3.4, 7.4, 7.5, 7.6.1, 7.8
Korea (Republic of) 8.1, 8.2.2.1, 8.3, 8.4.1.2, 8.4.2.1, 8.4.2.5, 8.4.2.9, 8.5.3, 8.6.2.3, 8.6.11, 8.7.2, 8.8.2, 8.9.2.3, 8.9.4, 8.9.6
United Kingdom 6.5.1, 6.6.4, 9.1, 9.3.1.1, 9.3.1.2, 9.5.2, 9.8.3.2
United States 5.6.6.4, 10.1.1.2, 10.1.1.3, 10.1.1.7, 10.2.1, 10.2.3, 10.3.1, 10.3.2, 10.6.1, 10.6.3, 10.6.6.2, 10.6.6.3, 10.7, 10.10.2, 10.13.2.1.6
see also individual countries
threats actions
Australia 2.8.2
China 4.5.5.3.6
Germany 5.4.1.2
India 6.8.1
United States 10.5
trials
remote-trial videoconferencing techniques 2.6.3, 2.6.10, 4.1.5, 4.6, 5.6.9, 6.6.7, 7.2.4.1.4, 9.6.13, 9.9.1.3, 9.9.5.1, 9.9.9, 11.6.2, 11.6.8.1, 11.6.8.4
see also individual countries
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement
Australia 2.10
Brazil 3.1.1, 3.2.1, 3.5.1.1, 3.11.2.1
China 4.1.1.2, 4.1.3.5, 4.3.2.5.4
definition 6.1.4
exclusive marketing rights (EMRs) 6.1.4.1, 6.1.4.4
India 6.1.1, 6.1.3, 6.1.4, 6.5.2, 6.6.1, 6.10.1
transitional period 6.1.4
United States 10.12.1.1
UK Intellectual Property Office (UKIPO) 6.2.1.6, 9.1.1.2, 9.2, 9.6, 9.7.3
Unified Patent Court 11.3.3
United Kingdom 2.1, 5.1.2, 5.6.1, 6.5.1, 6.6.4, 9.1–9.9, 10.1.1
alternative procedures 9.6.12, 9.6.17
Anton Piller (“search”) orders 9.6.5
appeals 9.1.1.1, 9.1.1.2, 9.3.1.1, 9.3.1.2, 9.6.14, 9.6.16, 9.7.5, 9.8, 9.9.14
Australia 2.1
barristers and solicitors 9.3.1.2, 9.6.13, 9.9.1
Brazil 3.1.1
Business and Property Courts of England and Wales 9.3.1.2, 9.3.1.3, 9.6.7.2
case management 9.2, 9.3.1, 9.6, 9.9.4–9.9.5
case management conference (CMC) 9.6.4, 9.9.1.3, 9.9.4, 9.9.5–9.9.7
Catholic churches 3.1.1
certificate of contested validity 9.4, 9.7.3, 9.9.13
Chancery Division of the High Court 9.3.1.2, 9.3.1.5, 9.6.14, 9.9
civil courts and judges 9.1.1, 9.2, 9.3, 9.6, 9.7, 9.8
civil remedies 9.1.1.1, 9.1.1.3, 9.5.3, 9.5.4, 9.5.5, 9.6.4.2, 9.6.5, 9.6.17, 9.7, 9.9.1, 9.9.5, 9.9.13
claim construction 6.5.1, 9.5.2, 9.6.3, 9.9.2–9.9.4
claim forms 9.6.3, 9.6.5.3, 9.9.2–9.9.4
closing written/oral submissions 9.6.13.2.6, 9.9.9
common law 9.1.1.1
Comptroller-General of Patents, Designs and Trade Marks 9.1.1.2, 9.2, 9.4, 9.6.6
concurrent expert evidence/witnesses 9.6.13.2.4
confidentiality issues 9.6.10, 9.6.15, 9.9.10
consequentials hearings 9.6.15–9.6.16, 9.7.4, 9.9.11
costs/expenses 9.1.1.1, 9.4, 9.6.1, 9.6.2.2, 9.6.5, 9.6.7, 9.6.17, 9.7.3–9.7.5, 9.9, 9.9.5, 9.9.12–9.9.14
counterclaims 9.5.5, 9.6.3, 9.6.4, 9.9.4.2
county courts 9.3.1.1
Court of Appeal 9.1.1.1, 9.1.1.2, 9.2, 9.3.1.1, 9.3.1.2, 9.3.2, 9.8, 9.9.14
court fees 9.6.2.2, 9.6.5.3, 9.9.5.1
cross-examination of evidence 5.6.1, 9.6.13.2.2–9.6.13.2.6, 9.9.5.3
damages 9.1.1.3, 9.5.3, 9.5.5, 9.6.5, 9.7.2, 9.9.1, 9.9.13
declaratory relief claims 9.5.3, 9.5.4
defenses 9.6.3, 9.6.5, 9.6.13, 9.7, 9.9.2, 9.9.4
delivery up and destruction orders 9.7.3.4
disclosures 9.3.1.2, 9.6.1, 9.6.4, 9.6.7, 9.6.10, 9.9.5.3, 9.9.6, 10.6.6
doctrine of equivalents 6.5.1, 9.5.2, 9.6.3.3
drawings 9.5.2
early case management (preparatory proceedings) 9.6.4, 9.9.5
England-and-Wales/Scotland/Northern-Ireland jurisdictions 9.1.1.2, 9.3.1.4, 9.3.1.5, 9.5.1, 9.6
EU withdrawal 9.1.1.2
European Patent Convention (EPC) 2.1.1, 5.1.2, 9.1.1.3, 9.4, 9.5.1, 9.5.2
European Patent Office (EPO) 5.1.2, 9.1.1.2, 9.1.1.3, 9.4
evidence 5.6.1, 9.6.4, 9.6.8, 9.6.13, 9.6.14, 9.9.5.3, 9.9.7, 9.9.9
examination of evidence 9.6.13.2.2–9.6.13.2.6, 9.9.5.3
expert evidence/witnesses 9.6.4, 9.6.8.2, 9.6.13, 9.6.14, 9.9.5.3, 9.9.7, 9.9.9
FRAND (fair, reasonable and nondiscriminatory) 9.5.4, 9.6.5.2, 9.7.1
“general form” injunctions 9.7
Germany 5.6.1
Hague Convention 9.6.2.1
High Court 9.1.1.2, 9.3.1.1–9.3.1.3, 9.4, 9.5.1, 9.6.14, 9.9, 11.2.1
hot-tubbing procedures 9.6.13.2.4
hybrid trials 9.6.13.1.2
importation prohibitions 9.5, 9.6
in camera (private) sittings 9.6.10, 9.6.14
information requests 9.6.3
injunctions 9.1.1.3, 9.5.3, 9.5.5, 9.6.4.2, 9.6.5, 9.7, 9.8.2, 9.9.5, 9.9.13
Intellectual Property Enterprise Court (IPEC) 9.1.1.1, 9.1.1.2, 9.3.1.2, 9.3.1.3, 9.6.2.1, 9.6.15, 9.9
interim injunctions 9.6.5, 9.6.4.2, 9.9.1, 9.9.5
interim-hearing costs 9.6.5.3.3, 9.9.12
inventive step 9.6.7.2
judges 9.1.1, 9.2, 9.3, 9.6, 9.6.14, 9.7, 9.8
judgments 9.6.14–9.6.15, 9.7, 9.8.3, 9.9.5, 9.9.10
judicial institutions 9.1, 9.3, 9.5, 9.8
judicial patent proceedings 5.6.1, 9.1, 9.2, 9.3, 9.4, 9.5, 9.6, 9.7–9.8
Korea (Republic of) 8.3.1.1
listing of cases and allocation of judges 9.6.14
mediators 9.6.17
multiple-trial scenarios 9.6.5.2
Northern-Ireland jurisdiction 9.1.1.2, 9.3.1.5, 9.5.1
novelty 9.6.3, 9.6.14, 9.7.4, 9.9.4
obviousness and insufficiency 9.6.7.2, 9.6.13.2.2, 9.6.14, 9.7.4
opening written/oral submissions 9.6.9.2, 9.6.13.2.1, 9.9.9
overview of the patent system 9.1
patent applications 9.1.1.3, 9.1.2
patent infringements 6.5.1, 9.1.1.2, 9.1.1.3, 9.2, 9.3.1.2, 9.4, 9.5, 9.6, 9.7, 9.8
patent institutions 5.1.2, 6.2.1.6, 9.1.1, 9.2, 9.6.2, 9.6.6, 9.7.3
patent invalidity 9.1.1.3, 9.2, 9.3.2, 9.4, 9.6.3, 9.6.7.2, 9.6.13.2.1, 9.7.3–9.7.4, 9.9.4
patent monopolies 2.1.1, 9.7.1, 10.1.1
patent revocations 9.3.1.2, 9.4, 9.5.5, 9.6.3, 9.7.3
Patents Court 9.1.1.2, 9.3.1.2, 9.6, 9.9.2–9.9.3, 9.9.9, 9.9.13, 11.2.1
“person skilled in the art” determinations 9.4, 9.5.2
pleas 5.6.1, 9.6.3, 9.6.7.2, 9.9.4
pre-action protocol 9.6.1, 9.9.2, 9.9.4
pretrial 9.6.11, 9.6.13, 9.6.14, 9.9.8
prior art 9.3.2, 9.6.3, 9.6.6, 9.6.8, 9.9.4
process infringements 9.5, 9.6.4, 9.6.7
product infringements 9.5, 9.6.4, 9.6.7, 9.7
public interest considerations 9.7.1
publication/dissemination of judgments 9.7.3, 9.9.13
“purposive construction” 9.5.2
quia timet actions 9.5.1
ratio decindendi system 9.1.1.2–3
reexamination of evidence 9.6.13.2.2, 9.6.13.2.5
requests for further information 9.6.3
responding to claims 9.6.3, 9.6.4, 9.9.2–9.9.5
Scotland jurisdiction 9.1.1.2, 9.3.1.4, 9.5.1
Shorter Trials Scheme 9.1.1.1
skeleton arguments 9.6.9.2, 9.6.13.2.1, 9.8.3, 9.9.9
sources of law 2.1, 9.1.1.2, 9.2, 10.1.1
stare decisis system 9.1.1.2
statements of case 9.6.3, 9.6.4, 9.9.4
stayed proceedings 9.1.1.3, 9.8.2
Supreme Court (formerly House of Lords) 6.5.1, 6.6.4, 9.1, 9.3.1.1, 9.3.1.2, 9.5.2, 9.8.3.2
technical primers and statements of agreed common knowledge 9.6.9
time to trial and expedition 9.6.4
trials 5.6.1, 9.6.11–9.6.14, 9.9.1, 9.9.5–9.9.9
United States 10.1.1
venue, jurisdiction and case assignment rules 9.6, 9.8.3–9.9.14
witnesses 5.6.1, 9.6.4, 9.6.8, 9.6.13, 9.9.5.3, 9.9.7, 9.9.9
see also Table of Cases and Table of Laws and Regulations
United Nations 2.10
United States 2.1.1, 4.1.3.5, 5.4.2.1.1, 5.6.1, 5.6.6.4, 6.1.4.1, 6.7.2, 6.11.3, 7.1.3, 7.2, 7.5.1.1, 7.9, 8.1, 8.6.1, 8.6.7, 10.1–10.15
Abbreviated New Drug Applications (ANDAs) 10.1.1.6, 10.3, 10.6.13.5, 10.13.2.1, 10.15
Administrative Law Judges (ALJs) 10.12
Administrative Patent Judges (APJs) 10.2.1.3, 10.2.2.4, 10.2.3, 10.15
administrative patent review proceedings 10.2, 10.3.3.3, 10.14
advisers 10.6.6.2, 10.6.9.2, 10.6.10, 10.6.11, 10.7.2, 10.12.2.10.5
alternative procedures 10.6.4
anti-suit injunction litigation 10.13.1.2
antitrust laws 10.1.1.3, 10.13.1, 10.13.2.1.6
appeals 5.9.1.4, 10.1.1.2, 10.1.1.5, 10.2.1, 10.3.1, 10.3.2, 10.6.7.1.5, 10.6.13.6, 10.7.2.2, 10.10, 10.12.2, 10.12.3, 10.15
attorneys 10.6.6, 10.6.10, 10.6.12, 10.6.13, 10.7, 10.7.3, 10.12.2, 10.12.3
bench trials 10.6.13, 10.6.13.5, 10.15
bifurcation (separate trials) ground rules 10.6.13.1, 10.6.13.5, 10.12.2.11.1
Bill of Rights 10.1.1
Biologics Price Competition and Innovation Act (BPCIA) 10.6.13.5, 10.13.2, 10.13.2.2, 10.15
border measures 7.9, 10.8, 10.12, 10.15
burden of proof 10.2.2.4.3.5, 10.6.7, 10.6.9, 10.6.13.2.3, 10.6.13.3, 10.15
business method patents 10.1.1.7, 10.2.1
California/Delaware/Texas cases 10.3.3.3, 10.6, 10.13.2.1.5, 10.15
case management 10.1.1, 10.3.4, 10.6, 10.12.2.9, 10.12.2.10, 10.13.2, 10.14
case management conference (CMC) 10.6.6, 10.6.9.2, 10.6.13.2
Central Reexamination Unit (CRU) 10.2.1, 10.2.2
challenges to improve case management 10.14
civil courts and judges 5.6.2.1, 10.1, 10.2.1, 10.2.2.4, 10.2.3, 10.3, 10.4, 10.5, 10.6, 10.10, 10.14, 10.15
civil remedies 6.7.2, 10.1.1.2, 10.1.1.7, 10.6.6, 10.6.7, 10.6.8.1, 10.6.10, 10.6.13.6, 10.7, 10.9, 10.10, 10.12.1.4, 10.12.3, 10.12.4, 10.13.2.1.4, 10.13.2.2, 10.15
claim construction 10.1.1.2, 10.2.2, 10.3.3, 10.5, 10.6.2, 10.6.6, 10.6.9.2, 10.6.13, 10.9, 10.12.2.8, 10.12.2.9, 10.15
claim forms 10.5, 10.6.2, 10.6.5, 10.15
closing written/oral submissions 10.6.13.2, 10.6.13.6
co-pending patent litigation 10.3.3
colonial background 10.1.1
confidentiality issues 10.2.2.4, 10.6.4, 10.6.7.1, 10.6.8.2, 10.6.12, 10.12.2.5, 10.12.2.7, 10.13.2.2
constitutionality concerns 10.2.3
contempt actions 10.9
contributory infringement claims 10.5.3.2
convoyed sales 10.7.2
costs/expenses 10.6, 10.7, 10.7.3, 10.14, 10.15
counterclaims 10.5, 10.6.5, 10.6.13.1, 10.7.2, 10.10.1, 10.12.1.1, 10.15
criminal proceedings 10.11
cross-examination of evidence 5.6.1, 10.6.11
damages 6.7.2, 10.6.6, 10.6.8.1, 10.6.10, 10.6.13, 10.7
“DAMP” “but-for” damages test 10.7.2.1
Daubert expert-witness framework 10.6.10, 10.6.11, 10.12.2.10.4, 10.15
de novo reviews 10.6.7.1.5, 10.12.3, 10.15
declaratory relief claims 5.6.2.1, 5.6.6.3, 10.2.2.4
defenses 10.1.1.4, 10.2.2, 10.3.3, 10.5, 10.6.5, 10.6.6, 10.6.8, 10.6.10.4, 10.12.1.2, 10.12.1.3, 10.12.2.5, 10.15
defenses to 35 U.S.C. 10.12.1.2, 10.12.1.3
depositions 8.6.7, 10.6.8.4, 10.6.11, 10.12.2.10
derivation proceedings 10.2.1, 10.2.2.6
design-around product infringements 10.9, 10.10.1.1
digital age 10.1.1.7, 10.2.1, 10.13.1
direct patent infringements 10.5.2, 10.6.6.3
disclosures 10.6.2, 10.6.6, 10.6.8, 10.6.10.4, 10.6.12, 10.15
discovery processes 5.6.1, 5.6.6.4, 8.6.7, 10.3.3.3, 10.6.2, 10.6.4, 10.6.6, 10.6.7.1, 10.6.8, 10.6.9.2, 10.6.12, 10.12.2, 10.15
district courts 10.1, 10.2.1, 10.2.2.4, 10.3, 10.4, 10.5, 10.6, 10.7.2.2, 10.10, 10.12, 10.13, 10.14, 10.15
doctrine of equivalents 10.1.1, 10.5.2
doctrine of experimental use 10.1.1.4, 10.5.3.2
doctrines 10.1.1, 10.5.2, 10.5.3, 10.14, 10.15
domestic-industry existence importation requirements 10.12.1.2, 10.12.2, 10.15
drawings 10.1.1.2, 10.2.2, 10.6.10.3
early case management (preparatory proceedings) 10.6.6, 10.6.9.2, 10.12.2.9, 10.12.2.10
economic power concerns 10.1.1.3
education/training provisions 10.2.1, 10.3.4, 10.6.6.2, 10.6.11, 10.12.2.10.5, 10.14
electronically stored information (ESI) 10.6.8
enforcement issues 10.9, 10.12.4, 10.12.5, 10.15
English law influences 10.1.1
enhanced/additional damages 10.6.13.6, 10.7, 10.7.2.3
equitable estoppel 10.1.1.4, 10.2.2, 10.5.2, 10.5.3, 10.6.13.5
European Patent Office (EPO) 10.2.1
evidence 5.6.1, 10.2.2, 10.5.1, 10.5.3, 10.6.3, 10.6.6, 10.6.10, 10.6.11, 10.6.13.3, 10.12, 10.15
ex parte reexaminations 10.2.1, 10.2.2
exhaustion doctrine 10.1.1.3, 10.1.1.4, 10.5.3
expert evidence/witnesses 10.2.2.4, 10.6.2, 10.6.6, 10.6.11, 10.6.13, 10.7.2, 10.12.2.10, 10.12.2.11.3, 10.15
Federal Circuit 10.1.1.2, 10.1.1.5, 10.1.1.7, 10.2.1, 10.2.2, 10.3.1, 10.3.3.2, 10.5, 10.6, 10.7, 10.10, 10.12.2, 10.12.3, 10.12.5.2, 10.13, 10.15
federal governmental and judicial structure 10.1, 10.3, 10.10
first-to-file rule 10.1.1.7, 10.3.3
Food and Drug Administration (FDA) 10.1.1.6, 10.13.2
forum shopping 10.1.1.5, 10.3.2, 10.13.1.2, 10.14
FRAND (fair, reasonable and nondiscriminatory) 10.7.1, 10.13.1
fraud 10.6.5
generic drugs 10.1.1.6, 10.3, 10.6.13.5, 10.13.2
hearsay 10.6.6.2, 10.12.2.11, 10.15
historical background 10.1.1, 10.3
importation prohibitions 7.9, 10.1, 10.3, 10.12.1, 10.12.2, 10.15
in limine motions 10.6.10.1, 10.6.10.4, 10.6.13.2, 10.9, 10.12.2.10, 10.6.13.2, 10.12.2.10.3
indirect patent infringements 10.5.2, 10.6.6.3
injunctions 5.9.1.4, 10.1.1.7, 10.6.7, 10.6.12, 10.6.13.6, 10.7, 10.10, 10.12.1.4, 10.15
inter partes reviews (IPRs) 10.2.1, 10.2.2.4, 10.2.2.5, 10.2.3, 10.3.3.3, 10.4, 10.15
interrogatories 10.6.8.3
jargon dictionary terms 10.5.1, 10.6.6.2
joinder of parties 10.6.13
judges 5.6.2.1, 10.1.1, 10.2.1, 10.2.2.4, 10.2.3, 10.3, 10.6, 10.10, 10.12.2, 10.13.2.1, 10.14, 10.15
judgment motions as a matter of law 10.6.13.3, 10.6.13.6
judgments 10.2.2, 10.2.3, 10.6.6, 10.6.9, 10.6.10, 10.6.13.3, 10.6.13.4, 10.9, 10.12.2, 10.12.2.9, 10.12.2.11.4, 10.13.2.1, 10.15
judicial institutions 10.1, 10.2, 10.3, 10.4, 10.5, 10.6.3, 10.10, 10.12, 10.14, 10.15
judicial patent proceedings 5.6.1, 5.6.3.3, 10.1, 10.2, 10.3, 10.4, 10.5, 10.6, 10.10, 10.12, 10.13, 10.14, 10.15
jury instructions 10.6.13.2.2, 10.6.13.6
jury selection/management logistics 10.6.13.2.3
jury trials 10.3.2, 10.6, 10.6.10.2, 10.6.13, 10.13.2.1.4, 10.15
legislature/executive/judiciary power structure 10.1.1, 10.10
Manual of Patent Examining Procedure 10.2.1
Markman hearings 5.6.1, 6.5.1, 10.5.1, 10.6.1, 10.6.6.1, 10.6.7.1, 10.6.9.2, 10.12.2.8
mediators 10.6.4
multi-track summary-judgment case-management 10.6.9.2
New Drug Applications (NDAs) 10.13.2, 10.15
new-trial motions 10.6.13.6
notice-pleading 10.6.5
novelty 10.2.1
obviousness and insufficiency 10.1.1.2, 10.1.1.3, 10.1.1.7, 10.2.1
Office of Unfair Import Investigations (OUII) 10.12.2, 10.12.3, 10.12.4
orders 10.6.7, 10.6.8, 10.6.12, 10.9, 10.12.2.5, 10.12.2.6, 10.12.2.7, 10.12.2.10
overview of the patent system 10.1, 10.3, 10.12, 10.15
parallel proceedings 10.3.2, 10.12.2, 10.12.5.1, 10.14, 10.15
patent amendments 10.2.1, 10.2.2.4
patent applications 3.1.6, 7.1.3, 7.2, 7.5.1.1, 10.2.1, 10.3.3
Patent Bar 10.2.1.1
patent infringements 7.9, 10.1, 10.2.1, 10.3, 10.4, 10.5, 10.6, 10.7, 10.9, 10.12, 10.13, 10.15
patent institutions 6.2.1.6, 7.2, 10.1, 10.2, 10.3, 10.6.10.2, 10.15
patent invalidity 10.1, 10.2.1, 10.2.2, 10.3, 10.4, 10.5.3, 10.6.5, 10.6.6, 10.6.7, 10.7.1, 10.13.2.1, 10.15
patent local rules (PLRs) 10.6.1, 10.6.2, 10.6.5, 10.6.6, 10.6.8, 10.12.2.2, 10.15
patent misuse defense 10.1.1.4, 10.5.3
patent monopolies 10.1.1.2, 10.1.1.3
Patent Office 6.2.1.6, 7.2, 10.1, 10.2, 10.6.12, 10.15
patent reissuance proceedings 10.2.2
patent revocations 10.2.1, 10.4
patent system history 10.1, 10.3
Patent Trial and Appeal Board (PTAB) 10.1, 10.2.1, 10.2.2.4, 10.2.2.5, 10.2.2.6, 10.2.3, 10.3, 10.6.12, 10.15
peripheral claims 10.1.1.2
“person skilled in the art” determinations 10.1.1.2
pharmaceutical products 10.1.1.6, 10.3, 10.6.13.5, 10.13.2
Phillips standard 10.2.2.4, 10.3.3.3, 10.5.1, 10.15
pleas 5.6.1, 10.6.5, 10.12.2.3, 10.15
post-grant reviews (PGRs) 10.2.1, 10.2.2.5, 10.3.3.3
post-trial motions 10.6.13.6, 10.7.2.3, 10.12.2.11.4
prejudgment interest 10.7, 10.7.2.4
preliminary injunctions 10.6.7, 10.15
preliminary relief 10.6.7, 10.15
Presidential import reviews 10.12.2, 10.12.3, 10.15
pretrial 10.6.2, 10.6.4, 10.6.6.1, 10.6.9.2, 10.6.10, 10.6.13
prior art 10.2.1, 10.2.2, 10.6.6, 10.6.7, 10.6.10.4, 10.12.2.10.3
product descriptions 7.5.1.1, 10.1.1.2, 10.2.2
protective orders 10.6.7.1, 10.6.8.2, 10.6.12, 10.12.2.5, 10.12.2.6, 10.12.2.7
public interest considerations 10.10.1, 10.12.2.5, 10.15
reasonable royalties 10.1.1.7, 10.6.10, 10.7.2, 10.7.2.2, 10.10.1.1, 10.13.2.2.2
redesigned product infringements 10.9, 10.10.1.1
reexamination of evidence 10.1.1.2
reexamination procedures 10.1.1.2, 10.2.1, 10.2.2, 10.4
remanded matters 10.10.1.2
responding to claims 10.6.2, 10.6.5, 10.6.8, 10.12.2.5, 10.15
Revolution 10.1.1
Section 337 investigations 10.12, 10.15
security bonds 10.6.7.1.3
Seventh Amendment to the US Constitution 10.1.1, 10.2.3, 10.3.2
software/hardware patents 10.1.1.7, 10.2.1, 10.6.12, 10.13.1
sources of law 10.1
special masters 10.6.6.2, 10.6.11
standard-essential patents (SEPs) 10.13.1
standard-setting organizations (SSOs) 10.13.1
statements of case 10.5, 10.6.2, 10.6.5, 10.12.2.10
stayed injunctions pending appeal 5.9.1.4, 10.10.1.1
stayed proceedings 5.9.1.4, 10.3, 10.12.2.4, 10.12.5, 10.13.2.1.4
substantial new question of patentability (SNQ) 10.2.2
summary judgments 10.6.9, 10.6.10, 10.12.2, 10.12.2.9, 10.15
Supreme Court 5.6.6.4, 10.1.1.2, 10.1.1.3, 10.1.1.7, 10.2.1, 10.2.3, 10.3.1, 10.3.2, 10.6.1, 10.6.3, 10.6.6.2, 10.6.6.3, 10.7, 10.10.2, 10.13.2.1.6
temporary restraining orders (TROs) 10.6.7
terms 10.5.1, 10.6.6.1, 10.6.6.2
threats actions 10.5
time limits and trial length logistics 10.6.13.2.3, 10.6.13.6, 10.7.2, 10.12.2, 10.12.2.5, 10.15
trial/hearing logistics 10.6.13.1, 10.6.13.2, 10.12.2.11.2
trials 5.6.1, 10.2.2, 10.3.1, 10.3.2, 10.6, 10.6.13
TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 10.12.1.1
vacatur motions to settle 10.6.13.6
venue, jurisdiction and case assignment rules 10.6.3, 10.10, 10.12.2.5.4, 10.12.5, 10.13.2.1.5, 10.15
verdict forms 10.6.13.4
video presentations 10.6.13.2, 10.12.2.10.5
winnowing claims 10.6.6
witnesses 5.6.1, 10.2.2.4, 10.6.3, 10.6.6, 10.6.10, 10.6.11, 10.6.13, 10.12.2.10
writs of certiorari 10.10.2
writs of mandamus 10.6.3, 10.6.7.1, 10.10.1
see also Hatch-Waxman; Table of Cases and Table of Laws and Regulations
United States Court of Appeals for the Federal Circuit (Federal Circuit) 10.1.1.2, 10.1.1.5, 10.3.1, 10.10, 10.12.2, 10.12.3
United States Customs and Border Protection 10.12.1.2, 10.12.2.1, 10.12.4, 10.15
United States International Trade Commission (USITC) 7.9, 8.4.2, 10.1, 10.3, 10.5, 10.8, 10.10, 10.12, 10.15
100-day proceedings early-resolution program 10.12.2.4
advisory opinions 10.12.4.4
assignment of judges 10.12.2.5.4
bifurcation (separate hearings) ground rules 10.12.2.11.1
biosimilar products 10.3, 10.13.2, 10.13.2.2, 10.15
case management 10.12.2.9, 10.12.2.10
claim construction 10.12.2.8, 10.15
claim preclusion 10.12.5.2
confidentiality issues 10.12.2.5, 10.12.2.7
definition 8.4.2, 10.1, 10.3, 10.12.1, 10.15
discovery 10.12.2.5.5, 10.12.2.7
discovery dispute management 10.12.2.7.3
district courts 10.12.5, 10.12.5.2, 10.15
early investigation management 10.12.2.5
early resolution programs 10.12.2.4
enforcement of remedy orders 10.12.4, 10.12.5, 10.15
evidentiary issues 10.12.2.11.3
exclusion/cease-and-desist orders 10.12.2.6, 10.12.4, 10.15
Federal Register Notices 10.12.2.5
FRCP contrasts 10.12.2.7
hearing logistics 10.12.2.11.2
hearings 10.12.2.11
interim initial determination (ID) early-resolution program 10.12.2.4
interlocutory USITC reviews 10.12.2.9
interventions 10.12.2.5.8
Office of Unfair Import Investigations (OUII) 10.12.2, 10.12.3, 10.12.4
patent investigation process 10.1, 10.3, 10.12.1, 10.12.2
patent law experts 10.12.2.11.3
personnel 10.12.2
post-final determination proceedings 10.12.4
post-hearing briefing and initial determination (ID) 10.12.2.11.4
pre-hearing submissions 10.12.2.5.5, 10.12.2.10
preliminary conferences 10.12.2.5.5, 10.12.2.5.7, 10.12.2.10.6
prior USITC determination effects 10.12.5.2
procedural rules 10.12.2.1, 10.12.2.2
protective orders 10.12.2.5, 10.12.2.6, 10.12.2.7
public interest submissions 10.12.2.5, 10.15
res judicata effects on district courts 10.12.5.2.3
responding to complaints 10.12.2.5.5
stayed proceedings 10.12.2.4, 10.12.5
summary determination 10.12.2, 10.12.2.9, 10.15
target dates 10.12.2.5.6, 10.15
temporary exclusion orders 10.12.2.6
timeline 10.12.2, 10.12.2.5.3, 10.15
typical investigation timeline 10.12.2
United States Patent and Trademark Office (USPTO) 6.2.1.6, 10.1.1.2, 10.2, 10.3.3.3, 10.4, 10.5.3.2, 10.6.10.2, 10.6.13.2, 10.10, 10.15
vacatur motions to settle, United States 10.6.13.6
venue, jurisdiction and case assignment rules
Boards of Appeal of the European Patent Office (EPO) 11.6.2
Germany 5.4.1.2.3, 5.4.3, 5.6.3, 5.6.9, 5.9
Korea (Republic of) 8.2.2, 8.3.1, 8.4.1, 8.6.2
United Kingdom 9.6, 9.8.3–9.9.14
United States 10.6.3, 10.10, 10.12.2.5.4, 10.12.5, 10.13.2.1.5, 10.15
Whyte, Ronald 10.6.1
winnowing claims, United States 10.6.6
witnesses
Australia 2.2.2.2, 2.2.2.3, 2.5.1, 2.6.7, 2.6.8, 6.6.8.4
Boards of Appeal of the European Patent Office (EPO) 11.6.6
Brazil 3.6.5
Germany 5.4.1.2.7, 5.4.1.3, 5.4.3.2, 5.6.1, 5.6.5.3, 5.6.7
Japan 7.2.4.1.4, 7.6.4.2, 7.6.7
Korea (Republic of) 8.4.2.6, 8.6.5, 8.6.7, 8.9
United Kingdom 5.6.1, 9.6, 9.9.5.3, 9.9.7, 9.9.9
United States 5.6.1, 10.2.2.4, 10.6.3, 10.6.6, 10.6.10, 10.6.11, 10.6.13, 10.12.2.10
World Intellectual Property Organization (WIPO) 3.2.3, 4.1.1.1, 4.1.3.5, 4.1.5, 6.2.1.6
Advisory Board of Judges 4.1.5
ePCT filing 3.2.3
World Trade Organization (WTO) 2.10, 4.1.3.5, 6.1.1, 6.1.4, 6.10.1
China 4.1.3.5
definition 6.1.4
Doha Declaration 2001 6.1.4.2, 6.1.4.4.5, 6.10.1
see also General Agreement on Tariffs and Trade (GATT 1947); TRIPS Agreement